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Abstract
Chronic stress and other emotional factors may have relevant impacts on pregnancy
outcomes because they are related to neuroendocrine changes that lead to alterations in
immunomodulation during pregnancy. In this quantitative prospective cross-sectional study,
the relationship of emotional lability, depression, and stress during pregnancy and the
development of preterm labor, preeclampsia, placental abruption, and low birth weight for
gestational age babies was examined. Additionally, social support scores were compared to
levels of stress/anxiety, depression, and emotional lability in pregnant women. Two hundred
and forty two pregnant women who received prenatal services at the National Institute of
Perinatology in Mexico City were evaluated during the 2nd or 3rd trimester of pregnancy and
followed until pregnancy termination. Logistic regression analyses showed that being single
significantly predicted preeclampsia and preterm birth, and the presence of social support
significantly decreased the likelihood of preterm birth development. In the logistic
regression model, family income significantly predicted the development of abruptio
placentae. MANCOVA results revealed a significant difference among the social support
categories on the combined dependent variables (stress/anxiety, depression, and emotional
lability). The ANCOVA reported significant differences between social support scores, and
stress/anxiety and depression scores. ANCOVA also showed significant differences between
the number of pregnancies and stress scores. A 2X2 factorial analysis of variance showed a
significant main effect of stress and depression on newborn weight. By promoting awareness
of the importance of emotional factors during pregnancy among healthcare workers and
pregnant women, this study contributed to positive social change.

Effect of Stress, Emotional Lability and Depression
on the Development of Pregnancy Complications
by
Estibalitz Laresgoiti Servitje

Master, Universitat Oberta de Catalunya, 2004
MSc, Instituto Politécnico Nacional, 2000
MD, Universidad Anáhuac, 1996

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Health Psychology

Walden University
August 2013

UMI Number: 3591710

All rights reserved
INFORMATION TO ALL USERS
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.

UMI 3591710
Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against
unauthorized copying under Title 17, United States Code

ProQuest LLC.
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor, MI 48106 - 1346

Dedication
I dedicate this work to my kids, Lucia, Andres, and Fernando. You have been the
reason to continue my personal growth. You inspire me to be a better professional, and a
better person. Lucia, Andres, and Fernando, I want you to remember that you can be
whatever you want to be. Be free, be respectful, and be joyful. This dissertation is the result
of many hours and months of hard study, as you know. You have been my always-present
companions in the pursuit of knowledge. May you also conquer your dreams, whatever
they may be, with hard work and perseverance.
I also dedicate this work to my husband, José. I know it has been hard for you as
well. Thanks for understanding my need to explore new things and to engage in hard-toreach but rewarding goals. I have finally finished. I will always work and learn, but my life
as a graduate student is finally ending. Thanks for growing with me.
To my parents, who have supported me throughout my learning journey, in many
ways. We have been through good and bad times, and we have learned from each other,
and from life. You gave me the bases to be able to fight for my dreams. Thank you.
I also want to dedicate this work to Dr. Cover. Diana, you have been a guide and a
friend. Thanks for helping me see things from different perspectives. Thanks for helping
me grow as a person.
To Dr. Decanini, who has been a mentor to me. You have supported me immensely
and helped me reach higher goals. Thank you for your generosity. I have learned so much
from you.

Acknowledgments
This dissertation would not have been possible without the help of my committee
members and my instructors. I would like to thank my dissertation chair, Dr. Robin OatisBallew, for her always available and kind support throughout the dissertation process. My
gratitude also goes to my other committee member, Dr. John Astin, whose prompt help and
assertive suggestions were of great help. I would also like to thank Dr. Kristen Beyer, who
was my University Research Reviewer, for her expertise. I could not have had a finer
committee.

Table of Contents
List of Tables ..................................................................................................................... vii
List of Figures..................................................................................................................... ix
Chapter 1: Introduction to the Study ................................................................................... 1
Introduction ................................................................................................................... 1
Background.................................................................................................................... 2
Problem Statement......................................................................................................... 3
Purpose of the Study ...................................................................................................... 4
Research Questions and Hypotheses ............................................................................. 5
Research Question 1 ................................................................................................ 5
Hypothesis 1 ............................................................................................................ 5
Research Question 2 ................................................................................................ 6
Hypothesis 2 ............................................................................................................ 6
Research Question 3 ................................................................................................ 6
Hypothesis 3 ............................................................................................................ 6
Theoretical and Conceptual Framework for the Study.................................................. 7
Nature of the Study ........................................................................................................ 8
Operational Definitions ................................................................................................. 8
Assumptions ................................................................................................................ 13
Scope and Delimitations .............................................................................................. 14
Limitations ................................................................................................................... 15
Significance of the Study............................................................................................. 16

i

Implications for Social Change ................................................................................... 16
Summary...................................................................................................................... 17
Chapter 2: Literature Review ............................................................................................ 19
Introduction ................................................................................................................. 19
Literature Search Strategy ........................................................................................... 20
Theoretical Foundation ................................................................................................ 20
The Stress Response and Its Association With Disease Development ....................... 22
The Stress Response During Pregnancy ...................................................................... 23
Stress-Related Immune System Activation During Pregnancy and ............................ 24
the Development of Disease ........................................................................................ 24
Stress/Anxiety and Its Relationship to Pregnancy Complications .............................. 25
Depression and Its Relationship to Pregnancy Outcomes ........................................... 26
Emotional Lability and Pregnancy Outcomes ............................................................. 27
Maternal Emotional Factors Associated With Changes in the Offspring ................... 28
The Importance of Social Support During Pregnancy ................................................ 30
Relationship of This Study to Previous Research ....................................................... 31
Summary and Conclusions .......................................................................................... 32
Chapter 3: Research Method ............................................................................................. 34
Introduction ................................................................................................................. 34
Research Design and Rationale ................................................................................... 34
Setting and Population ................................................................................................. 36
Sample and Sampling Procedure ................................................................................. 36

ii

Inclusion, Noninclusion, and Exclusion Criteria ................................................... 37
Power Analysis and Sample Size .......................................................................... 37
Procedures for Recruitment, Participation, and Data Collection................................. 38
Recruitment Procedures......................................................................................... 38
Demographics ........................................................................................................ 39
Data Collection ...................................................................................................... 39
Instrumentation ............................................................................................................ 41
Millon Behavioral Medicine Diagnostic ............................................................... 41
Social Support Questionnaire ................................................................................ 44
Medical Records .................................................................................................... 45
Measures of Social Support and Emotional Factors.................................................... 45
Social Support Network Scores ............................................................................. 45
Satisfaction With Social Support Scores ............................................................... 45
Overall Social Support Score ................................................................................ 46
Stress/Anxiety Scores ............................................................................................ 46
Depression Scores ................................................................................................. 47
Emotional Lability Scores ..................................................................................... 47
Nature of the Scale for Each Variable ......................................................................... 47
Data Analysis Plan ...................................................................................................... 49
Research Questions ..................................................................................................... 50
Research Question 1 .............................................................................................. 50
Research Question 2 .............................................................................................. 52

iii

Research Question 3 .............................................................................................. 53
Threats to Validity ....................................................................................................... 55
Ethical Procedures ....................................................................................................... 55
Summary...................................................................................................................... 56
Chapter 4: Results.............................................................................................................. 58
Introduction ................................................................................................................. 58
Data Collection ............................................................................................................ 59
Demographics Results ................................................................................................. 60
Descriptive Statistics ................................................................................................... 61
Psychosocial Factors ................................................................................................... 64
Preanalysis Data Screening ......................................................................................... 65
Hypothesis 1 Results ................................................................................................... 66
Logistic Regression Analysis for Preeclampsia .................................................... 66
Logistic Regression Analysis for Preterm Birth .................................................... 67
Logistic Regression Analysis for Abruptio Placentae ........................................... 68
Logistic Regression Analysis for Low Weight for Gestational Age ..................... 69
Hypothesis 2 Results ................................................................................................... 70
MANCOVA Results .............................................................................................. 70
Hypothesis 3 Results ................................................................................................... 72
Factorial ANOVA Stress/Anxiety, Emotional Lability, and Birthweight ............. 72
Factorial ANOVA Stress/Anxiety, Depression, and Birthweight ......................... 76
Factorial ANOVA Depression, Emotional Lability, and Birthweight .................. 79

iv

Summary...................................................................................................................... 83
Chapter 5: Discussion, Conclusions, and Recommendations ........................................... 85
Introduction ................................................................................................................. 85
Overview ............................................................................................................... 86
Demographics of the Study Population ................................................................. 86
Frequency of Pregnancy Complications ................................................................ 89
Interpretation of Hypothesis 1 Findings ................................................................ 90
Interpretation of Hypothesis 2 Findings ................................................................ 93
Interpretation of Hypothesis 3 Findings ................................................................ 95
Implications for Social Change and Recommendations for Action ............................ 97
Limitations and Future Recommendations .................................................................. 98
Limitations ............................................................................................................. 98
Future Recommendations ...................................................................................... 99
Conclusion ................................................................................................................. 100
References ....................................................................................................................... 102
Appendix A: Informed Consent ...................................................................................... 122
Informed Consent for the Effects of Stress/Anxiety, Depression and
Emotional Lability on the Development of Pregnancy Complications
Study (English) .............................................................................................. 122
Informed Consent for the Effects of Stress/Anxiety, Depression and
Emotional Lability on the Development of Pregnancy Complications
Study (Spanish) ............................................................................................. 128

v

Appendix B: Authorization to Use or Disclose PHI for Research .................................. 133
Authorization to Use or Disclose PHI for Research Purposes (English) .................. 134
Authorization to Use or Disclose PHI for Research Purposes (Spanish) .................. 136
Appendix C: Permission to Conduct Study ..................................................................... 138
Appendix D: Demographic Questionnaire ...................................................................... 139
Demographic Questionnaire (English) ...................................................................... 139
Demographic Questionnaire (Spanish)...................................................................... 140
Appendix E: Permission to Use Social Support Questionnaire....................................... 141
Appendix F: Short Version of the Social Support Questionnaire ................................... 143
Appendix G: Permission to Use MBMD......................................................................... 150
Appendix H: IRB Materials Approval ............................................................................ 151
Appendix I: Tables and Additional Information ............................................................. 152
Curriculum Vitae ............................................................................................................. 156

vi

List of Tables
Table 1. Maternal Descriptive Statistics…………………………………………………60
Table 2. Social Status and Monthly Family Income……………………………………..61
Table 3. Newborn Weight for Gestational Age………………………………………….62
Table 4. Maternal Illness…………………………………………………………………62
Table 5. Pregnancy Complications………………………………………………………64
Table 6. Categories of Total Social Support……………………………………………..65
Table 7. Stress/Anxiety, Depression, and Emotional Lability Scores………………...…65
Table 8. Regression Coefficients for Preeclampsia …………..…………………………67
Table 9. Regression Coefficients for Preterm Birth …………...………………………...68
Table 10. Regression Coefficients for Abruptio Placentae………………………………69
Table 11. Regression Coefficients for Low Weight for Gestational Age………….…….70
Table 12. ANCOVA Summary Table for Social Support on
Stress/Anxiety, Depression and Emotional Lability……………………………………..71
Table 13. Adjusted and Unadjusted Means for Stress/Anxiety,
Depression, and Emotional Lability………...…………………………………………...72
Table 14. Descriptive Statistics on Interactions Between Stress and Emotional Lability
with Newborn Weight as Dependent Variable…………………………………………..73
Table 15. ANOVA Summary Table for Stress/Anxiety and Depression
on Newborn Weight……………………………………………………………………..76
Table 16. Descriptive Statistics on Interactions Between Stress and Depression
With Newborn Weight as Dependent Variable………………………...………………..76

vii

Table 17. ANOVA Summary Table for Stress/Anxiety and Depression on
Newborn Weight ………………………………………………………………………...79
Table 18. Descriptive Statistics on Interactions Between Depression and Emotional
Lability With Newborn Weight as Dependent Variable…………………………………80
Table 19. ANOVA Summary Table for Emotional Lability and Depression
on Newborn Weight……………………………………………………………………...83
Table I1. Number of Babies in Uterus ………………………………………………....152
Table I2. Alive or Deceased Newborns ………………………………………………..152
Table I3. Newborn’s Weight at Delivery……………………………………………….153
Table I4. Newborn’s Sex……………………………………………………………….153
Table I5. Newborn Illness……………………………………………………………...154
Table I6. Newborn Conditions at Delivery…………………………………………….154
Table I7. Number of Maternal Infections During Pregnancy………………………….155
Table I8. Social Support Scores………………………………………………………..155

viii

List of Figures
Figure 1. Interaction of stress/anxiety and emotional lability on newborn weight ........... 74
Figure 2. Interaction of emotional lability and stress on newborn weight ........................ 75
Figure 3. Interaction of depression and stress on newborn weight ................................... 77
Figure 4. Interaction of stress and depression on newborn weight ................................... 78
Figure 5. Interaction of emotional lability and depression on newborn weight ................ 81
Figure 6. Interaction of depression and emotional lability on newborn weight ................ 82

ix

1
Chapter 1: Introduction to the Study
Introduction
The concept that emotional factors may regulate biological responses is not a new
one. Since the 1800s, medical professionals have reported the development of diseases in
individuals experiencing terrible fear, without finding explanations for fatal outcomes
(Risse, 1988). Among many researchers, the idea that emotions could have an effect on
health was seen as folklore (Angell, 1985). Cannon (1957) was one of the first to point
out the importance of social environments in biological systems. He identified the effects
of rage and fear on the nervous system, especially in the activation of the sympathetic
nervous system (Cannon, 1942). Years of research on the mechanisms that participate in
the stress response have helped scholars understand the multiple biological consequences
of this response and the emotional factors that may participate as triggers. Researchers
now know that the sympathetic nervous system participates in conjunction with the
hypothalamus-pituitary-adrenal axis in the stress response (Glei, Goldman, Chuang, &
Weinstein, 2007). Knowledge regarding the activation and the regulatory mechanisms
that participate in the response to stress has increased in recent years as well (McEwen,
2005).
One of the most relevant leaps into the understanding of emotional factors as
promoters of disease development was made by Ader (1975) in his
psychoneuroimmunological theory. He was the cofounder of the
psychoneuroimmunology field and the first to contradict the principle that the immune
system is autonomous. Ader showed that behavioral conditioning processes could
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suppress immune responses. He revealed the connections between the central nervous
system and the immune system (Pincock, 2012).
Psychoneuroimmunological concepts may be useful in several areas of medical
practice, such as endocrinology, rheumatology, infectology, and neurology. Nevertheless,
psychoneuroimmunology is especially important in the reproductive area, particularly
during pregnancy, when the immune system is finely regulated in order to promote
maternal acceptance of the fetus. Emotional phenomena during pregnancy may lead to
neuroendocrine changes that can alter this delicate regulation and lead to the development
of disease.
Several researchers have associated the role of stress and anxiety with the
development of preterm labor (Holzman et al., 2009; Rondo et al., 2003), but its
relationship with other psychosocial factors such as depression and emotional lability has
not been fully explored. Moreover, the association of depression and emotional lability
with the development of other pregnancy complications such as preeclampsia and
abruptio placentae has not been clearly established. The identification of psychosocial
risk factors for pregnancy complications may have positive implications for social change
because psychosocial phenomena represent modifiable risk factors in pregnancy. By
reducing risks for pregnancy complications, professionals can promote the birth of
healthy babies.
Background
Pregnancy is a delicate period in terms of immunorregulation. The mother’s
immune system must change from a fully responsive system into a regulated system that
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permits the existence of the fetus within the mother’s body. Because the immune system
is highly connected with neuroendocrine systems, it may be affected by increases in
catecholamines or stress hormones (Bierhaus et al., 2003). The delicate regulation of the
immune system during pregnancy may therefore be disrupted in the presence of chronic
stress or other emotional factors that activate neuroendocrine responses. The
psychoneuroimmunology of pregnancy has not been fully explored. While the role of
stress and anxiety on the development of preterm labor is a well-known phenomenon
(Dole et al., 2003; Kramer et al., 2009), the participation of emotional lability and
depression in the origins of other pregnancy complications and the role of social support
in the pregnant woman’s emotional life have not been clarified yet.
Problem Statement
Existing research has shown that emotional factors may increase the risk of
developing pregnancy complications (Roy-Matton, Moutquin, Brown, Carrier, & Bell,
2011). Stress, depression, and anxiety have been related to preterm labor (Dayan et al.,
2002; Rondo et al., 2003). However, there is a knowledge gap regarding the effect of
stress, depression, and emotional lability on the development of pregnancy complications
different from preterm labor. The goal of this study was to further understand the
participation of stress and anxiety in the development of pregnancy complications and to
determine whether other emotional factors, such as emotional lability and depression,
may be related to other adverse pregnancy outcomes.
The psychosocial environment of the pregnant woman, especially the availability
of social support, may have an influence on her emotional experience and how she
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perceives stressful situations. In order to better understand the role of social support on
emotional phenomena during pregnancy, this study compared the amount of perceived
social support to the presence of anxiety or depressive symptoms and to emotional
lability. Lack of social support may also increase vulnerability to stress/anxiety,
depression, or emotional lability in the pregnant woman.
Low birth weight in offspring has also been related to maternal stress and to
stress-induced dysregulation of the hypothalamic-pituitary-adrenal axis (Khashan et al.,
2008). However, there is still a need to determine whether depressive symptoms or
emotional lability may increase the risk of delivering a baby below the 10th percentile in
weight.
Deductive research was performed in this study, in which
psychoneuroimmunological and somatization theories were tested (Brown, 2007); all of
these theories applied to stress/anxiety, emotional lability, and depression during the
gestational period.
Purpose of the Study
The objective of this study was to quantitatively evaluate the effect of
stress/anxiety, emotional lability, and depression during the first trimester of pregnancy
on the development of any of the following pregnancy complications—preeclampsia,
abruptio placentae, and preterm delivery—and on newborn outcomes, controlling for the
effect of age, number of previous pregnancies, and socio-economic status (Creswell,
2009).
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This study was also designed to determine whether birthweight was lower in the
offspring of mothers with higher levels of stress/anxiety or emotional liability during
pregnancy. Additionally, the study explored the issue of whether the amount of perceived
social support may influence levels of stress/anxiety and/or emotional liability in
pregnant women.
Research Questions and Hypotheses
The following research questions were derived from the review of previous
literature in the area of stress, anxiety, depression, social support, and pregnancy
complications.
Research Question 1
Is there a significant relationship between the presence of stress/anxiety,
depression, and/or emotional lability, and the development of preeclampsia, abruptio
placentae, preterm labor, and low birthweight for gestational age babies?
Hypothesis 1
Null Hypothesis (H0): There is no significant relationship between stress/anxiety,
depression, and emotional lability scores and the development of preeclampsia, abruptio
placentae, preterm labor, and low birthweight for gestational age babies.
Alternative Hypothesis (H1): There is a significant relationship between
stress/anxiety, depression, and emotional lability scores and the development of
preeclampsia, abruptio placentae, preterm labor, and low birthweight for gestational age
babies.
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Research Question 2
Does the availability or unavailability of social support during pregnancy have a
relationship with the presence of stress/anxiety, emotional lability, and/or depression?
Hypothesis 2
Null Hypothesis (H0): The availability of social support does not have a
significant relationship with the presence of stress/anxiety, emotional lability, and/or
depression during pregnancy.
Alternative Hypothesis (H1): The availability of social support has a significant
relationship with the presence of stress/anxiety, emotional lability, and/or depression
during pregnancy.
Research Question 3
Is there a difference between the birthweight of the offspring of women who
experience high levels of anxiety or emotional lability during pregnancy and of those
who do not?
Hypothesis 3
Null Hypothesis (H0): There is no difference in newborn birthweight between
pregnant women who experience high levels of stress/anxiety or high emotional lability
scores during pregnancy and those who do not.
Alternative Hypothesis (H1): There is a difference in newborn birthweight
between pregnant women who experience high levels of stress/anxiety or high emotional
lability scores during pregnancy and those who do not.
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Theoretical and Conceptual Framework for the Study
The theoretical basis of this study comes from theories related to mind-body
interactions, such as functionalism, psychoneuroimmunogy, and allostatic load theories.
The allostatic and psychoneuroimmunology theories better explain physiological changes
associated with the development of diseases during pregnancy because they take into
account neuroendocrine alterations that can affect immune system modulation. During
pregnancy, there is an important regulation of maternal immune system responses so the
fetus will not be rejected by the mother (Guleria & Sayegh, 2007). Thus, the activation of
neuroendocrine pathways that can regulate the immune system may have deleterious
effects on pregnancy outcomes.
According to Coussons-Read’s (2005) psychoneuroimmunological theory,
neuroendocrine changes induced by the stress response during pregnancy can lead to the
secretion of proinflammatory cytokines and to a reduction of the cytokine IL-10, which is
essential for immune system regulation during pregnancy (Coussons-Read, Okun,
Schmitt, & Giese, 2005). This study relates to psychoneuroimmunological theory because
it proposes that emotional lability, stress, or depression may affect pregnancy’s
immunorregulation and can lead to the development of pregnancy complications related
to immune system activation, such as preeclampsia, preterm labor, and abruptio
placentae.
The maternal hypothalamic-pituitary-adrenal (HPA) axis undergoes adaptations
that can help decrease the effects of stress during pregnancy and glucocorticoid exposure
for the fetus (Brunton & Russell, 2008; Brunton, Russell, & Douglas, 2008). However,
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women who present pregnancy complications may not be able to regulate HPA
responses, or the induced stress response may override the body’s regulatory capacity.
According to theory of allostatic load, a lifetime of allostatic load may cause some
women to be particularly susceptible to the negative consequences of stress and the stress
response (Hilmert et al., 2008). The theory of allostatic load may be related to pregnancy
complications because chronic exposure to high levels of cortisol can modulate
progesterone levels and put pregnancy in danger (Nepomnaschy et al., 2006).
Nature of the Study
As the goal of the study was to identify the relationship between emotional factors
and the development of pregnancy complications, a prospective study was the most
adequate design. Prospective studies identify correlational relationships as well as risk
factors for disease development (Creswell, 2009). Different variables were assessed in
this study because three different research questions were evaluated.
Operational Definitions
Stress: Stress may be understood from both a psychological and physiological
perspective. Psychological stress is related to cognitive and emotional factors that are
associated with the appraisal of a threatening event. Physiological stress is the body’s
potentially damaging reaction to certain events (Monat, Lazarus, & Reevy, 2007).
Anxiety: Anxiety is defined as a sensation of chronic fear that exists without any
direct threat. It is commonly correlated with stress and with physiological stress reactions
such as tachycardia, hypertension, nausea, sleep disturbances, and hypercortisolemia
(Pinel, 2009).
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Stress/anxiety: As anxiety is highly correlated with stress, for the purpose of this
study, stress and anxiety will be considered as a single variable. They will also be
managed as one variable because the Millon Behavioral Medicine Diagnostic Test’s
Scale AA measures stress and anxiety and provides a single score for both factors
(Millon, Antoni, Minor, & Grossman, 2006).
Emotional lability: Patients with emotional lability experience intense endogenous
moods and periods of apathy and dejection, mixed with anger, anxiety or euphoria. They
have affect dysregulation and mood instability. Medical patients with emotional lability
account for approximately 6% of patients with physical illnesses (Millon et al., 2006).
Depression: Depressive symptomatology includes sadness, incapacity to
experience pleasure, despair, and incapacity to meet essential requirements of daily life
such as eating or maintaining personal hygiene (Pinel, 2009).
Low stress score: A score that ranges from 0 to 50 in the Millon Behavioral
Medicine Diagnostic Test’s Scale AA (Millon et al., 2006)
High stress score: A score that ranges from 51 to 100 in the Millon Behavioral
Medicine Diagnostic Test’s Scale AA (Millon et al., 2006).
Low emotional lability score: A score that ranges from 0 to 50 in the Millon
Behavioral Medicine Diagnostic Test’s Scale DD (Millon et al., 2006).
High emotional lability score: A score that ranges from 51 to 100 in the Millon
Behavioral Medicine Diagnostic Test’s Scale DD (Millon et al., 2006)
Preeclampsia: Preeclampsia is a pregnancy disorder that typically starts after the
20th week of gestation in which women present increased blood pressure (systolic
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pressure of 160mmHg or higher, or diastolic pressure of 110 or higher) and protein in
urine (2.0 grams or higher in 24 hours) as a result of kidney problems. Preeclamptic
patients also present an increase in serum creatinin (higher than 1.2mg/dl). Preeclampsia
affects the placenta, and it can affect the mother's kidneys, liver, and brain (National
Institutes of Health, 2012).
Preterm birth: Preterm labor is defined as labor that begins before 37 weeks of
pregnancy. It is also called premature labor (National Institutes of Health, 2013).
Abruptio placentae: The premature separation of the placenta, before the baby’s
birth. It is a cause of vaginal bleeding in the second half of pregnancy and is associated
with significant perinatal mortality and morbidity (Oyelese & Ananth, 2006).
Apgar score: The Apgar score is used in the delivery room for the assessment of
newborn babies. It evaluates respiratory effort, heart rate, muscle tone, reflex irritability,
and color. For each parameter, a score of 0 to 2 may be assigned, so the total score for
Apgar may be 10. The Apgar is evaluated at the first minute and 5 minutes after the
baby’s birth (Lopriore, Burk, Walther, & Beaufort, 2004)
Birthweight for gestational age: To evaluate if the offspring’s weight is adequate,
the weight is compared with gestational age, using male and female weight curves
according to each gestational week (Kramer et al., 2001).
Low birthweight for gestational age: Birthweight that falls in the 10th percentile or
below, according to male and female curves of weight for gestational age (Kramer et al.,
2001)
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Normal birthweight for gestational age: Birthweight that falls in the 50th
percentile, according to male and female curves of weight for gestational age (Kramer et
al., 2001)
High birthweight for gestational age: Birthweight that falls in the 90th percentile
or higher, according to male and female curves of weight for gestational age (Kramer et
al., 2001)
Social support: Defined as the availability of people on whom one can count.
Social support is about having someone who lets the patients know that they are loved,
valued, and cared about (Sarason, Levine, Basham, & Sarason, 1983).
High income: Family income higher than or equal to 85,000 Mexican pesos per
month, which equals approximately 6,600 USD per month, considering an exchange rate
of 12.7 (Asociación mexicana de agencias de investigacion de mercado y opinión
pública, 2012)
Medium income: Family income that ranges from 11,000 to 84,000 Mexican
pesos per month, which is an income that ranges from 860 to 6,500 USD per month,
considering an exchange rate of 12.7 (Asociación mexicana de agencias de investigacion
de mercado y opinión pública, 2012).
Low income: Family income that ranges between 0 to 10,000 Mexican pesos per
month, which is an income that ranges from 0 to 850 USD per month, considering an
exchange rate of 12.7 (Asociación mexicana de agencias de investigacion de mercado y
opinión pública, 2012).

12
Infections during pregnancy: Any type of infection that the woman might present
during pregnancy that requires pharmacological therapy was considered in this study. The
number of registered infections during pregnancy was recorded. The infections that were
included were upper respiratory tract infections, gastrointestinal infections, genitourinary
tract infections, and sexually transmitted diseases. Sexually transmitted diseases during
pregnancy were also evaluated because they have been related to adverse pregnancy
outcomes (Mullick, Watson-Jones, Beksinska, & Mabey, 2005)
HPA axis: Hypothalamic-pituitary-adrenal axis. The hypothalamus produces
hormones called vasopressin and corticotrophin-releasing hormone (CRH). The latter
stimulates the production of adrenocorticotrophic hormone (ACTH) from the pituitary.
ACTH acts on the cortex of the adrenal gland and stimulates the production of cortisol
(Vedhara & Irwin, 2007).
CRH: Corticotrophin releasing hormone (CRH) is produced by the hypothalamus
and stimulates the production of adrenocorticotrophic hormone (ACTH) by the pituitary
(Vedhara et al., 2007).
ACTH: Adrenocorticotropic hormone (ACTH) is produced by the pituitary gland
and stimulates the production of corticosteroids by the adrenal gland (Monat et al., 2007).
Cortisol: Cortisol is produced in the cortex of the adrenal glands and modulates
many stress-related responses. Cortisol effects include an increase in glucose levels and
the inhibition of reproductive functions. Cortisol has anti-inflammatory properties
because it can down-regulate immune processes, such as cytokine production and
leukocyte activation (Kendall-Tackett, 2010).
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Progesterone: Progesterone is a steroid hormone that belongs to the group of the
progestins. It is produced by the ovaries and the placenta, and it has a relevant role in the
maintenance of pregnancy (Pinel, 2009).
Cytokine: A small protein produced by a cell that can affect the behavior of other
cells. Cytokines act via specific cytokine receptors and have different functions (Murphy,
Travers, & Walport, 2008).
Psychoneuroimmunology: This field involves the study of the interactions among
the immune system, the nervous system, and behavior. It also considers the relationship
among the stress response, the neuroendocrine system, and the immune system (Vedhara
et al., 2007).
Assumptions
Although it is clear that the immune system participates in the initiation and the
pathophysiology of preeclampsia and preterm labor, its participation in the mechanisms
that lead to placental abruption are not fully known; neither have the participation of
neuroendocrine responses and the immune system been clearly elucidated in this
pregnancy complication. The activation of the immune system due to stress-induced
neuroendocrine changes is a well-known phenomenon, but the specific amounts of stress,
hormones, or neurotransmitters needed to induce immune system changes that will lead
to the development of disease may vary from one person to another and are not fully
known.
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Scope and Delimitations
In this study, I attempted to establish a correlational relationship between
emotional factors and the development of pregnancy complications; thus, internal validity
was relevant because possible internal validity threats were the selection of the sample
and the participation of confounding variables. These might have threatened my ability to
draw the correct conclusions regarding the correlational relationship between the
variables. To overcome issues regarding internal validity, a prospective cross-sectional
design and moderating variables, such as age at current pregnancy, were included in the
analysis to assess if the development of pregnancy complications could be attributed to
stress, depression, or emotional lability and not to confounding factors. This project only
explored psychoneuroimmunological theories during pregnancy regarding the effects of
emotional factors on preterm labor, preeclampsia, and abruptio placentae. Thus, its
results may only be applied to these disorders and not to others that may be present
during the gestational period. As the sample was not randomly selected and a
convenience sample was used, this study may have had issues regarding external validity
because only women who attended a perinatology hospital were evaluated, and these
women did not represent the absolute population of Mexican pregnant women.
Progesterone is essential for the adequate regulation of the immune system during
pregnancy (Guleria et al., 2007). Immune system changes related to the development of
disease in pregnancy have been associated with high levels of cortisol that decrease the
production of progesterone (Nepomnaschy, Sheiner, Mastorakos, & Arck, 2007;
Nepomnaschy et al., 2006). Due to this particular effect of cortisol on the secretion of
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progesterone during pregnancy, the results of this study may not be generalized to
pathologies not occurring during the gestational period. During chronic stress responses,
high levels of cortisol are related to suppression of various functions of the immune
system (Vedhara et al., 2007), which is different from what happens in the pregnant
woman under stress. In pregnancy, high levels of cortisol lead to decreased progesterone
levels. On the other hand, there may be possible generalizability of this study’s results to
other diseases that have been related to emotional factors in which high levels of cortisol
are present, such as asthma and allergic rhinitis (Elenkov, Iezzoni, Daly, Harris, &
Chrousos, 2005)
Limitations
This study had several limitations. First, no biological factors related to the stress
responses were be measured, such as cortisol, progesterone, epinephrine, serotonin, and
interleukin-10. A correlation between stress/anxiety scores, depression scores, and
emotional lability scores would have been highly appropriate to establish an association
among emotional factors, neuroendocrine and immune changes, and the development of
pregnancy complications. Second, this study included pregnant women of all ages
because I aimed to evaluate the effects of emotional factors in women of a wide range of
ages. However, there are certain pregnancy disorders, such as preeclampsia, that are more
prevalent before the age of 20 or after 40 (National institutes of health, 2012). The
inclusion of women younger than 20 years, or older than 40, may be a confounding factor
because age can increase the risk of developing preeclampsia per se. Third, this study
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may have had external validity issues because the population that was assessed was not
random and consisted of women mostly from low- to medium-income families.
The family income of pregnant women was considered because it may have had
an influence on the study’s outcomes, as low-income families in Mexico are associated
with relevant economic difficulties that increase the probability of stressful situations.
However, the level of social support in Mexican families is very high, and this may
attenuate the effects of stress generated due to economic factors.
The Millon Behavioral Medicine Diagnostic, which is the instrument that was
used to evaluate emotional lability, stress, and depression, had not been used to evaluate
pregnant women, nor had it been used in the Mexican population, which may also have
been a limitation to this study.
Significance of the Study
This study contributes to the knowledge regarding how pregnancy disorders may
be related to emotional factors. Many researchers have already documented the effect of
stress and anxiety on the development of preterm labor. However, there are research gaps
regarding the effect of stress on the development of other pregnancy complications, such
as preeclampsia and abruptio placentae. Furthermore, the participation of other emotional
aspects such as emotional lability and depression has not been clearly identified in
pregnancy complications.
Implications for Social Change
The practical applicability of this study and its implications for social change
reside in its identification of psychosocial risk factors that may contribute to the
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development of pregnancy disorders related to poor pregnancy and newborn outcomes.
The presence of a disabled child due to premature birth has important repercussions for
families and the society in which they live; this is why addressing risk factors for
pregnancy complications and preterm delivery can promote social change. The benefits
of this study will not be directly reflected, in the short term, in the mothers who
participated, or their children. However, the results obtained from the study offer
information regarding the importance of emotional and social support factors during
pregnancy that may help promote social change in the future. The information derived
from this study may allow phsysicans or health psychologists to implement new
parameters in health care attention for the pregnant woman and establish outlines for the
prevention of pregnancy complications related to psychosocial factors. By evaluating
psychosocial factors in the pregnant woman and establishing social support and stress
management programs, healthcare workers may be able to promote better psychosocial
environments during the gestational period, and this will lead to better pregnancy
outcomes and healthy newborns in communities, thus promoting social change.
Summary
This study explored the effects of emotional factors such as stress, depression, and
emotional lability on the development of preeclampsia, abruptio placentae, preterm labor,
and low birthweight for gestational age in offspring. It also assessed whether social
support has an effect on stress, depression, or emotional lability scores.
Several theories in the mind/body field may be related to this study, but this
study’s theoretical framework was based mostly in psychoneuroimmunology theories and
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allostatic load theory, which propose that emotional factors and stressful responses lead
to neuroendocrine changes that can alter cytokine profiles and immune system regulation.
A prospective cross-sectional design was used in order to evaluate if there is a
causal relationship between the dependent and independent variables. Anxiety/stress,
depression, and emotional lability scores were obtained by the application of the Millon
Behavioral Medicine Diagnostic Test. Social support was evaluated by using the short
version of Sarason’s Social Support Questionnaire.
The following chapter will address a review of the existing literature regarding
emotional factors and their relationship with pregnancy complications. The chapter
begins with the theoretical foundations on which this study was based and it then
describes the importance of the stress response and how neuroendocrine factors can affect
the regulation of the immune system during pregnancy. Finally, associations between
anxiety, depression, emotional lability, and low social support and pregnancy
complications are addressed.
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Chapter 2: Literature Review
Introduction
The literature review focuses on the relationship of emotional factors to maternal
well being during pregnancy. The review revealed the need for further research regarding
the biopsychological pathways involved in immune system activation during pregnancy
and the development of pregnancy complications such as preeclampsia and preterm labor.
More research is needed in the field of psychoneuroimmunology in pregnant women.
Researchers have focused on the participation of the immune system in pregnancy
disorders and, because the immune system may be affected by neurotransmitters derived
from psychological stress and emotional factors (Elenkov & Chrousos, 2006), it is
essential to identify psychological risk factors for negative pregnancy outcomes (Lobel et
al., 2008).
Maternal psychological environments are very important for pregnancy success
(Pluess, Bolten, Pirke, & Hellhammer, 2010). Environmental factors are frequently
ignored by health care professionals, who focus mainly on the biological aspects of
pregnancy, However, chronic stressors can negatively impact pregnancy outcomes
(Coussons-Read et al., 2005), and traumatic life events may also lead to health problems
through the modulation of the inflammatory response (Kendall-Tackett, 2009).
Preterm delivery is one of the most common pregnancy complications; it occurs
in 5-10% of pregnancies. It is mainly caused by spontaneous preterm labor, and it is
considered as a major obstetric complication. Spontaneous preterm labor has been
considered a psychosomatic entity (Dayan et al., 2002).
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Stress and the biological effects of the stress response can influence the
neuroendocrine, immune, and vascular processes in the maternal and fetal compartments
that have been implicated in the development of pregnancy complications (Wadhwa,
Culhane, Rauh, & Barve, 2001). The biologic pathways that participate in stress-induced
preterm labor, or other stress-related pregnancy complications, are not fully understood
yet (Kramer et al., 2009).
Literature Search Strategy
A search of literature was performed through electronic medical and psychology
databases. The databases used were Medline, PubMed, HighWire, EBSCO, OVID, and
PsycINFO. The key words used to conduct the search were stress, pregnancy, immune
system, preeclampsia, preterm labor, anxiety, depression, emotional lability, HPA axis,
cortisol, CRH, and abruptio placentae. There was no limit in terms of the years searched,
and the sources were mainly peer-reviewed journals.
Theoretical Foundation
The concept that stress can affect health is not a new one, and it comes from
various research fields, such as endocrinology, psychology, and neurobiology (Chrousos,
2009). Several theories relate the development of disease to emotional factors. Among
them are psychoneuroimmunology theories and allostatic load theory.
Psychoneuroimmunology theories propose that stress may induce nonspecific
changes in adrenocortical steroids, hormones, and neurotransmitters, which may provide
activation or inhibition signals to lymphocytes and, therefore, suppress or enhance
immune responses. (Ader, Felten, & Cohen, 2001). These theories also indicate that
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psychosocial stressors, by modulation of the immune system, may influence certain
diseases whose onset is influenced by proinflammatory cytokines (Kiecolt-Glaser,
McGuire, Robles, & Glaser, 2002). Coussons-Read et al. (2005) proposed a theory in
which they stated that stress, physiology, and immunity are importantly related to the
pregnant woman’s and baby’s health and that perinatal stress experiences may be harmful
to pregnancy success. They proposed that the presence of psychosocial stress, associated
to low social support and low-self efficacy, may induce cytokine production by the
maternal immune system and therefore lead to pregnancy complications (Coussons-Read
et al., 2005). Kendall-Tackett proposed a psychoneuroimmunological theory that links
psychological trauma with negative health effects based on empirical data obtained from
patients with childhood trauma, posttraumatic stress disorder, and abuse. He proposed
that traumatic life events increase levels of proinflammatory cytokines, which can alter
immune function and increase the risk of health problems such as coronary disease,
chronic pain syndromes, and so on (Kendall-Tackett, 2009).
The theory of allostatic load proposes that chronic stress promotes a cumulative
cost to our neuroendocrine responses that may affect health outcomes (Glei et al., 2007).
The concept of “allostatic load” was initially introduced to explain the cumulative
physiological load that results from adaptive responses to challenges, in which wear and
tear of the systems occur and promote biological dysregulation of the hypothalamicpituitary-adrenal (HPA) axis, sympathetic nervous system activation (SNS), and the
accumulation of allostatic load (Seeman, McEwen, Rowe, & Singer, 2001). Chronic
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stress, thus, can lead to immune system modulation and alters metabolic and
cardiovascular processes (Glei et al., 2007).
The concept that stress can affect health is not a new one, and it comes from
various research fields, such as endocrinology, behavior, and neurobiology (Chrousos,
2009) .The evaluation of allostatic load in medical practice can help to predict various
health outcomes related to cardiovascular disease, physical function, and mortality (Glei
et al., 2007). Allostatic load in pregnancy may have relevant consequences because of the
effects that cortisol and catecholamines have on the pregnant woman’s immune system
and overall physiology. Because of this, during normal pregnancies, the maternal HPA
axis undergoes adaptations that can help decrease the effects of stress during pregnancy
and glucocorticoid exposure for the fetus (Brunton et al., 2008; Brunton et al., 2008).
If the bases of the mind-body problem and its social influences are fully
understood, researchers may be able to modulate some of the social factors that are
contributing to the development of disease, making a positive change in this field.
The Stress Response and Its Association With Disease Development
Cannon (1957) studied the physiology of emotion and is considered the first
scientist to do research in this area. He showed that during exposure to stress, the
sympathetic-adrenal system induces changes in blood pressure and glucose levels.
Cannon also defined the term homeostasis, which describes how physiological processes
maintain a steady state in the body (Cannon, 1942; Cannon, 2002). Selye (1950) unified
many of the observations done by other researchers who tried to explain how living
organisms respond to stress, in the concept termed the general adaption syndrome. He
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pointed out that stress can put life in danger, unless it is followed by an adaptive
response. According to Selye, stress is an interaction between damage and defense that
induces changes in the nervous and the endocrine systems that initiate with activation of
the hypothalamus and the pituitary (Selye, 1950).
Selye used the term stress and proposed the general adaptation syndrome to
explain the consequences of stress and the physiological and psychological events that
occur in response to stress (Chrousos & Gold, 1992). The stress response activates the
sympathetic nervous system (SNS; (Chrousos, 2009) and the HPA system (McEwen,
2007).
Pregnant women may also be susceptible to the effects of the stress response
(Coussons-Read et al., 2005), and the physiological events that participate in this
response can lead to pregnancy complications such as preterm delivery (Wadhwa et al.,
2001)
The Stress Response During Pregnancy
During pregnancy and lactation, the HPA axis undertakes important adaptations
that aim to decrease the effects of stress on the mother and her offspring (Brunton et al.,
2008). Throughout the gestational period, the HPA axis’s adjustments play an important
role in modulating the effects of the stress response in the pregnant woman and reducing
fetal exposure to maternal glucocorticoids, which are hormones produced by the adrenal
gland cortex, and it responds differently depending on the stage of pregnancy. Lower
cortisol levels at the beginning of pregnancy may promote implantation (Brunton et al.,
2008), while higher levels are associated with early pregnancy loss. (Nepomnaschy et al.,
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2007). During the first trimester of pregnancy the woman is more vulnerable to the
effects of stress, and the stress response may affect the length of gestation (Hobel &
Culhane, 2003).
An HPA hyporesponsiveness to immune challenges has also been reported in the
third trimester of normal pregnancies, due to a reduced activation of the CRH-secreting
neurons (Brunton et al., 2005). It is possible that chronic stress during pregnancy may
lead to cortisol and progesterone changes later in pregnancy, which has been related to
pregnancy complications. Prospective studies are still needed to provide answers
regarding the effects of psychological stress during the gestational period (Nepomnaschy
et al., 2007) and the biological mechanisms that participate in the stress-related override
of the HPA hyporesponsiveness during pregnancy.
Stress-Related Immune System Activation During Pregnancy and
the Development of Disease
Stress-related interactions between the nervous system and the immune system
have been related to pregnancy complications due to deregulation of the immune and
endocrine systems (Coussons-Read et al., 2005). Psychosocial stress has been identified
as a risk factor for preterm birth and low birth weight for gestational age. These factors
have been related to altered levels of corticotrophin-releasing hormone, which may have
relevant immunoregulatory effects that can make the pregnant women more susceptible
to infections and other complications (Hobel et al., 2003). Studies in mice have shown
that stress reduces progesterone levels, and this decrease has been related to premature
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delivery and abortion, because progesterone has important immunomodulating properties
(Arck, Hansen, Mulac Jericevic, Piccinni, & Szekeres-Bartho, 2007).
Because many pregnancy complications can be related to an altered regulation of
the immune system (Guleria et al., 2007) and the immune system can be modulated by
emotional factors that activate the stress response (Graham, Christian, & Kiecolt-Glaser,
2006), psychosocial factors such as anxiety, depression, emotional lability, and low social
support could be associated with the development of some pregnancy complications.
Stress/Anxiety and Its Relationship to Pregnancy Complications
Anxiety symptoms such as feelings of worry, apprehension, and nervousness are
common among pregnant women (Catov, Abatemarco, Markovic, & Roberts, 2010), and
anxiety disorders are considered risk factors for adverse pregnancy outcomes, which is
why prompt identification and treatment of these disorders is warranted during pregnancy
(Littleton, Breitkopf, & Berenson, 2007). Preterm birth is a pregnancy complication that
is highly related to stress and severe life events. Severe life events present during the 6
months before pregnancy may pose a higher risk for preterm birth (Khashan et al., 2009).
Anxiety related to pregnancy has been independently associated with preterm birth as
well (Catov et al., 2010; Kramer et al., 2009) Moreover, high levels of anxiety are related
to increased cortisol levels during pregnancy (Dayan et al., 2002) and to the release of
corticotropin–releasing hormone (CRH) , which have been linked to preterm delivery
(Mancuso, Schetter, Rini, Roesch, & Hobel, 2004; Wadhwa et al., 2001). Researchers
have considered CRH a placental clock that participates in pregnancy termination
because it may foretell when labor will start. CRH concentrations may be help predict
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50% of women at risk for preterm delivery (Inder et al., 2001). However, not only stressrelated hormones and cytokine changes are increased in the pregnant woman who is
under stress. Holzman et al. (2009) found an association between high norepinephrine
and dopamine urine levels and a higher risk for spontaneous preterm labor. This indicates
that activation of the sympathetic nervous system participates in stress-induced
pregnancy complications as well (Holzman et al., 2009).
Although most researchers have reported an association between psychosocial
factors and pregnancy complications, others have not found such relationship. Littleton et
al. (2006) performed a meta-analysis to evaluate the correlations between anxiety
symptoms and adverse perinatal outcomes and did not find any associations (Littleton et
al., 2007).
Depression and Its Relationship to Pregnancy Outcomes
Depression is another stress-related mental health concern that impacts many
pregnant women. The age range in which the onset of depressive symptoms occurs in
women is between 20 to 40 years, which is the age range when most women may become
pregnant. As the incidence of major depressive disorder in pregnant women has been
reported to be as high as 16%, it is important that healthcare workers become aware of
the frequency of depressive symptoms in pregnant women and the health consequences
that undetected or untreated depression can have on pregnancy outcomes (Marcus &
Heringhausen, 2009). The presence of depression during the implantation period is not
related to pregnancy cancellation and does not affect in vitro fertilization success rates
(Lintsen, Verhaak, Eijkemans, Smeenk, & Braat, 2009). However, depression may affect
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outcomes later in pregnancy because it is associated with higher levels of cortisol and a
decrease in HPA axis negative feedback (Von Werne Baes, de Carvalho Tofoli, Martins,
& Juruena, 2012). Increases in cortisol levels during pregnancy have been associated with
the release of placental CRH, a hormone that is a key player in the initiation of labor
(Dayan et al., 2006). Pregnant women with depression have a higher risk of developing
preterm labor, delivering a low birthweight for gestational age baby (Grote et al., 2010),
or delivering a baby with a low Apgar score (Goedhart et al., 2010; Grote et al., 2010).
Also, obesity and stressful events may increase the effect of depression on preterm labor
(Li, Liu, & Odouli, 2009). Furthermore, after delivery, the prevalence of
proinflammatory cytokines and high cortisol levels have been associated with postpartum
depression (Corwin & Pajer, 2008). This is why high cortisol levels and high
psychological reactivity to stress during pregnancy may help identify those women who
are likely to develop postpartum major depression (Nierop, Bratsikas, Zimmermann, &
Ehlert, 2006).
Depression can also be considered a risk factor for preeclampsia (Bansil et al.,
2010) because moderate to severe depression has been related to a three-fold increased
risk for developing preeclampsia (Qiu, Sanchez, Lam, Garcia, & Williams, 2007)
Emotional Lability and Pregnancy Outcomes
Pregnant women also experience other psychosocial stressors that can exert a
physiological impact. Approximately one-half of pregnant women tend to report
insomnia, and others may present mood lability, anxiety, or depression during the third
trimester (Dorheim, Bjorvatn, & Eberhard-Gran, 2012; Marques et al., 2011). According

28
to Tam and Chung (2007), emotional lability can be present during the postpartum blues,
presenting as mood irritability, anxiety, headaches, and sleep disturbances, but it should
also be differentiated from depression if the symptoms persist (Tam & Chung, 2007).
Emotional lability should be identified in pregnant women because pregnant women tend
to report mood lability throughout the gestational period (Clark, Skouteris, Wertheim,
Paxton, & Milgrom, 2009). According to McDonald (1968), women with labor
difficulties tend to be more sensitive and apprehensive; those women who develop
preterm labor tend to have more negative attitudes toward pregnancy and emotional
immaturity; and women with preeclampsia tend to be unhappy and under stress
(McDonald, 1968). Patients with affective disorders and schizophrenia should also be
monitored during the gestational period because they have a higher risk of fetal and
neonatal complications as well (Jablensky, Morgan, Zubrick, Bower, & Yellachich,
2005).
Maternal Emotional Factors Associated With Changes in the Offspring
Stress and anxiety during pregnancy not only affect pregnancy outcomes; animal
models have shown that stress during pregnancy has programming effects on the
development of the offspring and, in humans, it is related to increased infant illnesses
during the first year of life (Beijers, Jansen, Riksen-Walraven, & de Weerth, 2010). For
example, children exposed prenatally to stress have a 25% increased risk of being
hospitalized due to a severe infectious disease and a 30% increased risk of presenting a
less severe infectious disease in childhood (Nielsen, Hansen, Simonsen, & Hviid, 2011).
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While stress during the first trimester has a relevant effect on the length of
pregnancy (Hobel et al., 2003), chronic maternal stress during the third trimester and the
postpartum period increases maternal basal salivary cortisol and affects stress-related
behavior and growth in the male offspring and HPA axis functioning in female and male
offsprings (Emack, Kostaki, Walker, & Matthews, 2008). Male offsprings of prenatally
stressed-rats display increased anxiety behavior, and female and male offsprings of
stresses rats also display an increased production of CRH that may be related to altered
glucocorticoid negative feedback mechanisms in the limbic system (Brunton & Russell,
2010).
The fetal exposure to the neuroendocrine changes during maternal stress can also
result in intrauterine programming that leads to early onset of certain adult disorders like
an increased risk of coronary artery disease, diabetes, and stroke (Hobel et al., 2003).
Furthermore, maternal psychological stress during pregnancy has been related to immune
system changes in the offspring and promotes a higher incidence of allergic processes in
the offspring such as asthma, eczema, urticaria, and so on. (Entringer et al., 2008).
As previously mentioned, emotional factors may play a role in the development of
pregnancy complications and on newborn outcomes. This is why the identification of
possible stress mediating or buffering factors is relevant. According to Häusser (2012),
social support and social identity may have a stress-buffering effect (Häusser,
Kattenstroth, van Dick, & Mojzisch, 2012) and may decrease the incidence and
prevalence of stress-related diseases (Thoits, 2011). The buffering effect of social
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support is also relevant in pregnant women, on whom social support may decrease the
effects of stressful situations on pregnancy outcomes (Dunkel Schetter, 2010)
The Importance of Social Support During Pregnancy
Social support has been defined as the availability of people on whom a certain
individual can rely on, and the existence of people that let the patient know that they are
valued and cared about (Kim, Sherman, & Taylor, 2008; Vangelisti, 2009). The
relationship between stressful events and the development of disease is stronger among
subjects who report lower levels of social support compared to those with high levels of
support. This may be due to the fact that social support acts as a moderator of the stress
response (Sarason & Sarason, 2009)
The presence of maternal stress can increase the incidence of preterm birth.
However, not all women who experience stress during pregnancy deliver preterm. This is
why vulnerability to stress should also be considered, and the behavioral mechanisms that
mediate the effects of stress during pregnancy should be evaluated (Hobel & Culhane,
2003).
Pregnancy, by itself, is associated with anxiety and stress because of
psychological adjustments that have to take place due to life changes of the pregnant
woman and the lack of emotional adjustment may increase the risk of pregnancy and
neonatal complications. However, one of the most important risk factors for negative
pregnancy outcomes is the absence of social support, because it affects maternal
emotional well-being (Elsenbruch et al., 2007). Less social support is also correlated with
a higher incidence of depressive symptoms in pregnant women (Spoozak, Gotman,
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Smith, Belanger, & Yonkers, 2009) and to increased anxiety symptoms as well (Littleton
et al., 2007). According to Rodriguez et al. (1999), the adjustment to pregnancy and the
presence of relevant medical symptoms during pregnancy can be affected by the amount
of perceived stress and social support (Rodriguez, Bohlin, & Lindmark, 1999).
On the other hand, prenatal social support has been positively correlated with
infant birth weight through adequate fetal growth. Therefore, interventions should
promote support within the pregnant woman’s social network, and psychosocial risk
factors that may lead to adverse pregnancy and neonatal outcomes should be identified
(Feldman, Dunkel-Schetter, Sandman, & Wadhwa, 2000).
Relationship of This Study to Previous Research
Most researchers who have focused on evaluating the effects of stress on
pregnancy complications have developed cohorts and prospective cross-sectional studies
in which pregnant women were assessed at the beginning of pregnancy and followed
until delivery (Coussons-Read et al., 2005; Nepomnaschy et al., 2006). Others evaluated
emotional factors in pregnant women during the second and the third trimesters (Nierop
et al., 2006; Rahman, Bunn, Lovel, & Creed, 2007).
This study employed similar statistical methods to those used in other studies that
have evaluated the effects of emotional factors on the development of different pregnancy
complications. Dayan et al. (2002) conducted a cohort study to evaluate the role of
anxiety and depression on the development of preterm labor and they performed a
logistic regression analysis to search for associations (Dayan et al., 2002). Other
researchers have also performed logistic regression analyses to evaluate the role of stress,
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anxiety or depression on spontaneous preterm birth (Holzman et al., 2009; Kramer et al.,
2009; Nasreen, Kabir, Forsell, & Edhborg, 2010). Analysis of variance (ANOVA) is
useful in evaluating the role of psychosocial factors in pregnancy as well. Elsenbruch et
al. (2007) compared three groups of social support with regard to pregnancy outcomes by
using ANOVA (Elsenbruch et al., 2007). In this study, factorial ANOVA and
multivariate analysis of covariance (MANCOVA) were performed in the analysis of the
role of psychosocial variables on the development pregnancy complications.
Summary and Conclusions
Pregnancy has been related to anxiety by itself because of the uncertainty that
comes with the prospect of having a new baby. It is also a vulnerable state for women
because of the multiple physiological changes that take place so the baby can grow in the
mother’s womb. The immune system is highly regulated during pregnancy and it is this
regulation that permits the mother to tolerate the semiallogenic fetus (Guleria et al.,
2007). Due to this delicate regulation and to the intricate connections between the
immune and the nervous systems, psychoneuroimmunological theories have proposed
that emotional factors may be able to affect immune system homeostasis during
pregnancy and lead to pregnancy disorders (Coussons-Read, Okun, & Simms, 2003).
The HPA axis also undergoes changes during pregnancy. In normal pregnancies, women
usually present an HPA axis hyporesponsiveness promoted by the progesterone
metabolite, allopregnanolone (Brunton et al., 2008). This HPA regulation favors the
continuing of pregnancy. For example, implantation is related to lower cortisol levels;
and later in pregnancy, these mechanisms help decrease the effect of glucocorticoid
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exposure in the offspring (Kapoor, Dunn, Kostaki, Andrews, & Matthews, 2006)
However, it is believed that severe stressful events or chronic stress during pregnancy
may annul pregnancy’s HPA axis regulatory mechanisms and lead to pregnancy
complications through the activation of the immune system (Coussons-Read et al., 2005).
Furthermore, high fetal exposure to maternal cortisol has been related to neuroendocrine
changes in the newborn (Emack et al., 2008).
Low social support has also been linked to pregnancy complications and this may
due to increased stress levels in these women (Zachariah, 2009). There are still research
gaps regarding the mechanisms that lead to changes in HPA axis hyporesponsiveness
(Douglas, Brunton, Bosch, Russell, & Neumann, 2003), the pathways that mediate an
immune system shift towards Th1 responses, and to increased vulnerability to the effects
of emotional factors during pregnancy.
The following chapter explains the nature of this study, in which the participation
of stress, emotional lability, and depression were evaluated in the development of
pregnancy complications.
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Chapter 3: Research Method
Introduction
This chapter includes a description of the study design, where it took place, and
the type of population that was evaluated. It includes a rationale for why this particular
design was selected to answer the research questions. The sample characteristics, the
power analysis that was performed, and the required sample size will also be presented.
In this chapter, the instrumentation, the data collection process, the analysis, and the
ethical considerations will be described as well.
The objective of this study was to evaluate the effect of stress, anxiety, and
depression during pregnancy on the development of preeclampsia, abruptio placentae,
and preterm delivery, as well as on newborn birthweight. The relationship was controlled
for the effect of age, number of previous pregnancies, and socio-economic status
(Creswell, 2009). I also evaluated whether perceived social support may have an effect
on stress/anxiety, depression, and emotional lability scores during pregnancy.
Research Design and Rationale
A prospective, cross-sectional, quasiexperimental design was performed in which
individuals were not randomly assigned because a convenience sample was studied
(Creswell, 2009). Prospective studies are appropriate for evaluating whether certain
conditions may participate as risk factors for specific outcomes. A cross-sectional
approach was used because variables were looked at during a particular point in time.
The sample included only women who were attended at the National Institute of
Perinatology, and this delimitation is why the study was considered quasi experimental.
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Researchers who have evaluated the effects of emotional factors on pregnancy
complications have also performed prospective cross-sectional studies (Feldman et al.,
2000; Kramer et al., 2009) or used similar approaches (Khashan et al., 2009).
Three research questions were explored that included different variables. For the
first research question, logistic regression analyses were performed in which the
dependent categorical variables were preeclampsia, preterm labor, abruptio placentae,
and low birthweight for gestational age. The independent, numerical variables were
stress, depression, emotional lability, and social support scores. The moderating or
intervening variable was the Social Support Questionnaire score. The control variables
were age at pregnancy and number of previous pregnancies. For the second research
question, a multivariate analysis of covariance (MANCOVA) was performed in which
stress/anxiety scores, emotional lability, and depression were the quantitative dependent
variables, and the Social Support Questionnaire score was coded as a categorical
independent variable that was coded as high, medium, or low. The covariates were
mother’s age at pregnancy and the number of previous pregnancies. For the third research
question, a factorial ANOVA was performed in which the dependent quantitative variable
was newborn birthweight and the mother’s stress/anxiety scores (coded as high or low)
and emotional liability scores (coded as high or low) were the independent categorical
variables. More information about data analysis and hypotheses will be covered later in
this chapter.
In this prospective study, data were collected at different points. The first data
collection was performed at any point during pregnancy and consisted of the application
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of the Millon Behavioral Medicine Diagnostic Test and the Social Support Questionnaire,
as well as the gathering of demographic information. The trimester in which the
participant was evaluated was registered for control purposes. The second data collection
took place at delivery or pregnancy termination. The information that was collected at
this last point included the socioeconomic status of the mother, type of delivery, time of
delivery (number of gestational weeks), development of pregnancy complications,
newborn Apgar score, and birthweight. Delivery and newborn information was obtained
from medical records, with required authorization.
Setting and Population
The setting of the study was the National Institute of Perinatology located in
Mexico City, Mexico, which is a government-owned research hospital. This hospital
attends a high volume of patients per day who require perinatal healthcare. The
participants were pregnant women ranging from 18 to 40 years old who were attended at
this hospital. Women who were included in this study were those who were in the first
trimester, second trimester, and third trimester of pregnancy.
Sample and Sampling Procedure
Due to difficulties in transportation in Mexico City and to the large sample
required for the realization of this study, all participants were recruited from a
perinatology hospital that provides health care to a large number of patients per day. A
convenience sample was used for this study because all patients were recruited
nonrandomly at the same hospital.
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Inclusion, Noninclusion, and Exclusion Criteria
In order to meet the study’s inclusion criteria, participants needed to be pregnant
women in the first, second, or third trimester of pregnancy and between the ages of 18
and 40 years. Women of all socioeconomic statuses were included in this study. The
noninclusion criteria, which were the criteria by which pregnant women were not asked
to participate in the study, were as follows: being pregnant with a history of gestational
hypertension in previous pregnancies. Exclusion criteria, which were the criteria by
which participants would have their study participation suspended, were as follows: (a)
voluntarily requesting to leave the study, (b) not continuing pregnancy assessment at the
National Perinatology Institute and not being reachable to evaluate pregnancy outcome,
and (c) having pregnancy loss before the 20th week of gestation. Criterion-based sampling
was used because participants were selected from a group of pregnant women attended at
a public hospital. All women were evaluated at the National Perinatology Institute in
Mexico City.
Power Analysis and Sample Size
A search for effect sizes between stress, anxiety or depression, and pregnancy
complications and effect sizes between stress and newborn outcomes was performed
using medical and psychological databases. The effect size for anxiety and medical
disorders during pregnancy is d = 0.808, and the effect size for depression and medical
disorders during pregnancy is d = 0.725 (King et al., 2010). The effect size for stress and
preterm labor is d = 0.840 and r = 0.387, respectively (Lobel et al., 2008). The effect size
for previous life stress and pregnancy complications is R2 = 0.146, r= 0.382 (Norbeck &
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Tilden, 1983). The effect size for low social support and pregnancy complications is R2 =
0.082, r = 0.286 (Elsenbruch et al., 2007). The effect size for stress and low birthweight
is R2 = 0.67, r = 0.818 (Rondo et al., 2003). The correlation between negative life events,
low social support, and illness development is r = 0.48 (Sarason, Sarason, Potter, &
Antoni, 1985).
A power analysis was performed considering an accepted value for power at 0.80
and an alpha level at 0.05. Considering that depression and anxiety have a prevalence
during pregnancy of approximately 18% (Karmaliani et al., 2009) and an effect size of r
= 0.382 for pregnancy complications, a total of 265-275 women were required to be in
the study.
Procedures for Recruitment, Participation, and Data Collection
Recruitment Procedures
Women were asked to participate while they were in the waiting room for any
pregnancy appointment. I was the only person administering the tests and questionnaires
to the participants. Information regarding the objectives of the study and participation in
it was provided. If women agreed to participate, they read and signed an informed
consent letter (Appendix A), acknowledging that they had received appropriate
information and were eager to freely participate in the study. The approximate total time
that participants took to finish the MBMD test and the SSQ was 35 minutes. If they were
interrupted by being called for an appointment, they finished after consultation. Women
were given a telephone number where they could reach me in case they did not deliver at
the Perinatology Institute. An email address and a cell phone were registered for all
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participants so that I could contact them if they delivered elsewhere. Women were
informed that the second phase of data collection would be done by obtaining
information from their medical records. They were informed that they could contact me
at any time throughout the study, and that if they wished to know their scores from the
MBMD Test or the Social Support Questionnaire, I could contact them after delivery. All
participants received the telephone number and the e-mail address with which they could
contact me.
Demographics
The demographic data collected at study enrollment during the first trimester of
pregnancy included age at current pregnancy, number of previous pregnancies, and the
gestational week at which the evaluation was taking place.
Data Collection
The data collection tools that were used in this study were a short demographics
questionnaire, the Millon Behavioral Medicine Diagnostic Test, and the short version of
the Social Support Questionnaire. Medical records were essential for the second phase of
the data collection process, in which pregnancy outcomes were recorded.
Because this is was a prospective cross-sectional study, data were collected at two
points. The first data collection effort was performed during the first, second, or third
trimester of pregnancy. Data that were obtained at this point were demographic
information such as age at current pregnancy, the number of the current pregnancy,
gestational week at which the evaluation took place, social status, and economic status.
The data that were obtained with the MBMD test were stress/anxiety scores, depression
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scores, and emotional lability scores. With the SSQR, perceived social support scores
were acquired. Because the hospital where the study took place has a high volume of
patients, the approximate calculated time for the first data collection effort was 4 months.
Two hundred and seventy-five patients were supposed to be included. After the initial
data acquisition, the numerical and categorical variables were entered into an SPSS
database, and women were followed until pregnancy termination. After delivery, the
development of preeclampsia, preterm labor, or abruptio placentae was confirmed in the
medical record of the mother. The gestational week in which delivery occurred and the
presence of maternal infections during pregnancy were obtained as well. Apgar scores
and birthweight were collected from the newborn’s medical record.
The tests were completed in paper format. All the written tests and demographic
questionnaires were kept in a locked filing cabinet. The written tests and questionnaires
were kept in a locked filing cabinet at my home, and the SPSS file with all the results was
saved in my laptop computer’s hard disk and Time Capsule.
During the first data collection process, the MBMD test, the SSQ, and the
demographic questionnaire were kept in a privacy envelope for each participant. The
MBMD test only showed the assigned study number for each participant and her
birthdate. The envelope showed the participant’s birth date and the assigned participant
number as well. However, this information was not easy to associate with the participant.
For example, if the participant’s birth date was June 5, 1965 and her assigned number
was 57, the number that appeared on her envelope was 57-050665. Every envelope was
kept in a filing cabinet until all participants were gathered. After completing the sample, I
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took out the MBMD test from each participant and scored the test by using Pearson’s Q
local software. I entered the test’s answers manually. Pearson’s Q local software required
that the test’s answers be entered twice in order to eliminate typing errors. The MBMD
test scores were only linked to the participant by the number formed by the assigned
number and the participant’s birthdate. Nobody at Pearson Assessments was able to
identify the participants because they only had their assigned study numbers and
birthdates. The results obtained from Pearson Assessments were saved in a .pdf file for
each participant; the files were saved in my computer, and each file had the participant’s
birthdate and the study number that was assigned to each participant. All files were
password protected. The test results were uploaded into an SPSS password-protected file.
The SPSS files that contained the databases with the test results were locked and saved in
my computer’s hard disk and Time Capsule. I kept the information regarding the
participant’s name, medical record number, birthdate, phone number or email, and
assigned study number in a password-protected file in my computer.
The second data collection process involved the use of medical records. I filled in
the required information on a sheet of paper that had the participant’s assigned study
number; the information was then uploaded to the SPSS database. This sheet of paper
was kept in the participant’s envelope and locked in a filing cabinet as well.
Instrumentation
Millon Behavioral Medicine Diagnostic
The MBMD is based on the Millon Behavioral Health Inventory (MBHI), which
is one of the most frequently used health inventories in the United States. It is distributed
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in the United States by Pearson Assessments, and I have been authorized by this
company as a test administrator. The estimated administration time is 20-25 minutes.
The MBMD is composed of 165 items and 29 clinical scales, and it is useful in
the evaluation of psychological factors that may influence the clinical course or the
treatment of medically ill adult patients. The phenomena evaluated by the MBMD are
response patterns (disclosure, desirability, and debasement), negative health habits
(alcohol, drugs, eating, caffeine, inactivity, and smoking), psychiatric indications
(anxiety-tension, depression, cognitive dysfunction, emotional liability, and
guardedness), coping styles (introversive, inhibited, dejected, cooperative, sociable,
confident, nonconforming, forceful, respectful, oppositional, and denigrating), stress
moderators (spiritual absence, illness apprehension, functional deficits, pain sensitivity,
social isolation, and future pessimism), treatment prognostics (interventional fragility,
medication abuse, information discomfort, utilization excess, and problematic
compliance), and management guides (adjustment difficulties and psychiatric/
psychosocial referral (Millon et al., 2006).
The reliability of the MBMD test, estimated by internal consistency and test-retest
analyses, showed an internal consistency of rtt,=.79 and a median test-retest coefficient
of rtt = .83. Regarding the validity of the MBMD test, the MBMD scales were correlated
with other measures such as BDI and the BSI depression scales (Millon, 2012). The testretest reliability was estimated with a sample of N = 41, and the results obtained were as
follows: psychiatric indications (rtt = .79 to .88); coping style (rtt = .71 to .90); stress
moderators (rtt =. 78 to .92); treatment prognostics (rtt = 72 to .88); and management
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guide (rtt = .78 to .81). The median for all scales is rtt = .83 (Millon, 2012). Reviewers of
the MBMD scales have reported variable to good internal consistency and indicated that
the scales addressing psychosocial features showed alpha coefficients close to or superior
to 0.8 (Strack, 2008).
The scales included in the MBMD were validated by an item-sorting procedure in
which various medical professionals placed the items into scales for which they were
initially written. The items that were sorted correctly by most of the medical
professionals were maintained on the test. Afterward, the items were correlated with
many other measures that evaluated similar phenomena to each of the scales. For
example, the MBMD depression scale was correlated with the BDI (.87) and with the BSI
depression scale (.58) (Millon, 2012).
The convergent correlations between MBMD scales and other measurement
divides with well established validity were moderate to high, with the exception of two
aspects: problematic compliance and utilization excess. The test authors refer that these
may be due to complex and variable patient behavior (Millon et al., 2006).
The various scales of the MBMD may be relevant to different clinicians. For
example, psychometricians are interested in the results of all scales, but clinicians
(physicians, surgeons, etc.) are mostly interested in psychiatric indicators and stress
moderators because these refer to patient characteristics that are directly influencing
clinical decisions (Strack, 2008). The Spanish Q local MBMD answer sheets will be used
to administer the test, and the scores for the MBMD test will be obtained by using
Pearson Assessment’s Q local software.
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Social Support Questionnaire
The Social Support Questionnaire (SSQ) evaluates two aspects of social support:
the amount of perceived social support and the degree to which this social support is
satisfying. The SSQ has an alpha coefficient of internal reliability of 0.97, which is a high
reliability; criterion validity tests demonstrated a negative correlation between the SSQ
and a depression scale (Sarason et al., 1983). For this study, the short form of the Sarason
Social Support Questionnaire will be used, which is also known as the SSQSR. The short
form of the SSQ has high internal reliability and a high correlation with the SSQ. It
consists of 12 items that have scores that range from 1 (very dissatisfied) to 6 (very
satisfied). The SSQSR odd-numbered items assess the participants’ social support
network, and the even-numbered items assess the extent to which they are satisfied with
the level of support received. Satisfaction items are rated on 6-point scales in which 1 =
very dissatisfied and 6 = very satisfied. The maximum score for the social support
network items is 54, and the maximum score for the items that evaluate satisfaction with
social support is 36. The scores that reflect the number of individuals in the patient’s
network as well as the satisfaction with support are obtained by summing across items.
The total social support score will be calculated by adding the score from the social
support network and the score from the satisfaction with social support items. The
maximum score will be 90. This questionnaire takes less than 5 minutes to administer
(Sarason, Sarason, Shearin, & Pierce, 1987), and it will be hand scored by a research
assistant to decrease the risk of potential researcher bias.
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Medical Records
The data that was collected from mothers’ and newborns’ medical records during
the first week after delivery was the number of infections during the first, second, and
third trimesters; the development of pregnancy complications such as preeclampsia,
abruptio placentae, and preterm labor; the gestational week in which delivery occurred;
neonatal Apgar scores; and the newborn’s birthweight. The newborn’s weight was also
considered as low, adequate, or high for gestational age by using weight-for gestationalage curves. The socioeconomical status was also obtained from the social worker’s
evaluation in the medical record.
Measures of Social Support and Emotional Factors
Social Support Network Scores
These scores were obtained using the short version of the Sarason’s Social
Support Questionnaire that consists of 12 items. The six odd number items assess the
participants’ social support network. The maximum score for the social support network
items is 54 (Sarason et al., 1987).
Satisfaction With Social Support Scores
These scores were obtained using the short version of the Sarason’s Social
Support Questionnaire (SSQ) that consists of 12 items. The six even-numbered items
assess the extent to which they are satisfied with the level of support received.
Satisfaction items are rated on 6-point scales where 1 = very dissatisfied and 6 = very
satisfied. The maximum score for the items that evaluate satisfaction with social support
is 36 (Sarason et al., 1987).
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Overall Social Support Score
The total social support score was calculated by adding the score from the social
support network items and the score from the satisfaction with social support items. The
maximum score was 90.
High social support score. High social support was defined as having an overall
social support score that ranged from 68-90 in the SSQ.
Medium-high social support score. Medium social support was defined as
having an overall social support score between 46-67 in the SSQ.
Medium-low social support score.Medium social support was defined as having
an overall social support score between 23-45 in the SSQ.
Low social support score. Medium social support was defined as having an
overall social support score between 0-22 in the SSQ.
Stress/Anxiety Scores
These scores were calculated by using the MBMD Test’s Anxiety-Tension Scale
AA. The maximum score was 100. It is believed that high scores on this scale may suffer
from numerous somatic disorders (Millon et al., 2006).
Low stress score. Low stress score was defined as having a stress/anxiety score
between 0-50 in the MBMD.
High stress score. High stress score was defined as having a stress/anxiety score
between 51-100 in the MBMD.
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Depression Scores
These scores were calculated by using the MBMD Test’s Depression Scale BB.
The maximum score was 100. High scores on this scale are likely to intensify the
discomfort of their psychological and physical problems (Millon et al., 2006).
Emotional Lability Scores
These scores were calculated by using the MBMD Test’s Emotional Lability
Scale DD. The maximum score was 100. High scorers on this scale tend to experience
endogenous mood changes, apathy and dejection (Millon et al., 2006).
Low emotional lability score. Low emotional lability was defined as having a
stress/anxiety score between 0-50 in the MDMB.
High emotional lability score. High emotional lability was defined as having a
stress/anxiety score between 51-100 in the MBMD.
Nature of the Scale for Each Variable
Age at current pregnancy. This variable was considered as a numerical variable.
Number of previous pregnancies. This variable was considered as a numerical
continuous variable
Gestational week at which the evaluation is taking place. This variable was
considered as a numerical variable.
Current social status. This variable was considered as a nominal categorical
variable and it will be coded as married, single, divorced, widowed.
Economical status. This variable was considered as a ordinal variable and it was
coded as high-income, medium-income, low-income.
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Number of maternal infections during pregnancy. This variable was considered as
a numerical interval value.
Development of preeclampsia. This variable was considered as nominal
categorical variables and was coded as yes/no.
Development of abruptio placentae. This variable was considered as nominal
categorical variables and was coded as yes/no.
Development of preterm labor. This variable was considered as nominal
categorical variables and was coded as yes/no.
Depression score. This variable was considered as a numerical interval variable.
Anxiety/stress score. This variable was considered as a numerical interval
variable.
Emotional lability score. This variable was considered as a numerical interval
variable.
Social support score. This variable was considered as an interval variable for
logistic regression and as ordinal (coded as low, medium, high) for the multivariate
analysis of covariance.
Newborn’s weight. This variable was recorded as numerical interval variable.
Newborn’s weight for gestational age. It was considered as an ordinal variable
depending on its relationship with gestational age. It was coded as low, normal or high
for gestational age.
Newborn’s Apgar scores at the first minute and after five minutes. This variable
was considered as a numerical interval variable.
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Data Analysis Plan
The IBM SPSS Statistics 20.0 Premium software was used for data analysis.
A data file was created which will contain the variable names, their type, and their
values (George & Paul, 2010). A study number was assigned to each participant. The
study number will consist in the participant’s birthdate and an assigned study
number. For example if the participants birth date was June 5th, 1965 and her
assigned number was 57, the number that was assigned to her was 57-050665. All
the participant’s data was assigned to this number and this ensured confidentiality of
the information because only the researcher was able to associate the data with each
participant. The first data was entered to the data file as soon as the first data
collection phase ends. The rest of the data was entered for each participant after
pregnancy termination.
Before performing the analysis, data cleaning procedures were performed.
The preanalysis data screening assured the accuracy of the data and consisted on
examination of the data by performing descriptive statistics and frequency
distribution. I verified that all cases had values within possible range and that all
cases had values that corresponded to the coded values for each variable.
A research assistant from the National Institute of Perinatology controlled the
quality of the data that was analyzed. Additionally, a search for missing data was
done. The missing data was handled by replacing missing data with the mean values.
The preanalysis data cleaning also included the assessment of outliers (extreme
values) because these could create problems in multivariate analyses, such as those

50
that were performed in this study. Outliers were identified using Mahalanobis
distance and the researcher decided which outliers should be dropped from further
analysis (Mertler & Vannatta, 2010).
Finally, data was tested for normality, linearity, and homoscedasticity
because these are three assumptions for multivariate statistical analyses. Univariate
normality was tested by using the normal probability plot (normal Q-Q plot),
skewness and kurtosis, and the Kolmogorov-Smirnov statistic. If data were
substantially deviated from normal, I evaluated if data transformations using a
square root transformation or a log transformation were required. After
transformation of the data, normality was reevaluated. Linearity is important in
multivariate analyses because many techniques are based on linear relations.
Linearity was be evaluated with residual plots. Homoscedasticity was evaluated by
using the Levene’s test to assess the homogeneity of variances (Mertler et al., 2010).
Before performing the analyses for the three research questions, an analysis of the
demographical variables was performed, which consisted in frequency distribution and
central tendency measures (mean, mode, median).
Research Questions
Research Question 1
Is there a significant relationship between the presence of stress/anxiety,
depression and/or emotional lability with the development of preeclampsia, abruptio
placentae, preterm labor and/or the delivery of low birthweight for gestational age
babies?
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Null hypothesis (H0). There is no significant relationship between stress/anxiety,
depression, emotional lability, and the development of preeclampsia, abruptio placentae,
preterm labor and low birthweight for gestational age.
Alternative hypothesis (H1). There is a significant relationship between
stress/anxiety, emotional lability and depression and the development of preeclampsia,
abruptio placentae, preterm labor, and low birthweight for gestational age.
Logistic regression analyses were performed to evaluate the degree in which
preeclampsia, abruptio placentae, preterm birth and low birth weight-for gestational age
(coded as present or not present) were predicted by anxiety/stress, emotional liability and
depression (independent quantitative variables). Logistic regression aims to classify
participants into groups. It may be considered as an extension of multiple regression, but
in logistic regression the dependent variable is categorical (Mertler et al., 2010).
Four sets of logistic regressions were performed, one for preeclampsia, one for abruptio
placentae, one for preterm labor, and one for low birth weight for gestational age, as
dependent variables. The independent variables were stress/anxiety scores, emotional
lability scores and depression scores. Moderating or intervening variables for regression
analysis were the total social support score. The control variables were age at pregnancy,
family income, and social status.
Considering that depression and anxiety have a prevalence during pregnancy of
approximately 18% (Karmaliani et al., 2009), and an effect size of r=0.382 for pregnancy
complications, for the regression analysis, a total of 265-275 women should have been
included in order to have a power of .80
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The main output components that helped interpret the results from logistic
regression were goodness of fit indices, the-2 log likelihood, Cox &Snell R Square and
Nagelkerke R square. R2 indicates the proportion of variability in the dependent variable
that may be accounted for by predictor variables. The last component of the output was
the Wald statistic, in which R was the partial correlation coefficient between the
independent variables and the dependent variable (Mertler et al., 2010).
Research Question 2
Does the availability or unavailability of social support during pregnancy have a
relationship with the presence of stress/anxiety, emotional lability and or depression?
Null hypothesis (H0). The availability of social support does not have a
significant relationship with the presence of stress/anxiety, emotional lability and/or
depression during pregnancy.
Alternative hypothesis (H1). The availability of social support has a significant
relationship with the presence of stress/anxiety, emotional lability and/or depression
during pregnancy.
A multivariate analysis of covariance (MANCOVA) was performed to evaluate
the relationship between stress/anxiety scores, emotional lability and depression, as
quantitative dependent variables; and the social support score (coded as high, mediumhigh, medium-low, low) as a categorical independent variable. The covariates were
mother’s age at pregnancy and the number of previous pregnancies.
MANCOVA searches for statistically significant mean differences between
groups after adjusting a newly created dependent variable for differences on covariates. It
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is useful when researchers want to control de effects of concomitant variables (Mertler et
al., 2010).
MANCOVA’s results initially showed homogeneity of variance-covariance with
Box’ test. If the Box’s test was significant, then Pillai’s Trace was used for multivariate
test statistic. However, if equal variances were assumed with Box’s test, then a Wilk’s
Lambda statistics was used when interpreting the homogeneity of regression slopes. The
results of homogeneity of regression slopes were examined using the F ratio and the p
value and effect size for each factor’s main effect (Mertler et al., 2010).
Research Question 3
Is there a difference between the birthweight of the offsprings of women who
experience high levels of anxiety, depression or emotional lability during pregnancy, and
those who do not?
Null hypothesis (H0). There is no difference in newborn birthweight between
pregnant women who experience high levels of stress/anxiety, depression or high
emotional lability scores during pregnancy, compared to those who do not.
Alternative hypothesis (H1). There is a difference in newborn birthweight
between pregnant women who experience high levels of stress/anxiety, depression or
high emotional lability scores during pregnancy, compared to those who do not.
A factorial design experiment was done because two independent variables were
analyzed regarding their independent or simultaneous effects on the dependent variables
(Creswell, 2009).
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When research designs include more than one factor, they are called factorial
designs. Factorial analysis of variance (ANOVA) tests the mean differences with respect
to some dependent variables. It also allows the researcher to test group differences and to
test for interaction effects between various levels of the independent variables (Mertler et
al., 2010).
Three Factorial ANOVAs (Two-Factor Design) were performed. The first one
evaluated if there were significant differences in newborn birthweight for gestational age
between the mother‘s stress/anxiety scores (coded as high and low), and emotional
lability scores (coded as high and low). The dependent quantitative variable was newborn
birthweight; the independent categorical variables was stress/anxiety and emotional
lability. The second one evaluated if there were significant differences in newborn
birthweight for gestational age between the mother‘s stress/anxiety scores (coded as high
and low), and depression scores (coded as high and low). The dependent quantitative
variable was newborn birthweight; the independent categorical variables were
stress/anxiety and depression. The third one evaluated if there were significant
differences in newborn birthweight for gestational age between the mother‘s depression
scores (coded as high and low), and emotional lability scores (coded as high and low).
The dependent quantitative variable was newborn birthweight; the independent
categorical variables were depression and emotional lability.
For the 2 x 2 factorial analysis, in which 4 groups were included, considering an effect
size of r = 0.818, the required size was at least 9 participants in each group, for a total of
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36 participants. Considering a 10% of attrition, and additional 4 participants were added
so that each group had at least 10 participants, and a total of 40 participants.
For the factorial ANOVA results, a line plot displayed factor interactions. If lines
crisscrossed or overlapped, then an interaction was present. In order to evaluate if the
interaction was statistically significant, the F ratio and the p level from the factorial
ANOVA test was evaluated.
Threats to Validity
A possible threat to external validity in this study was the inclusion of mostly
medium and low-income women because these are the patients attended at the
Perinatology Institute. High-income women in Mexico tend to receive medical care at
private hospitals and this is why the study results may not be generalized to patients from
all economical status. On the other hand, there is a known interaction between low
birthweight for gestational age and preeclampsia, which may be independent from
emotional factors which may pose a threat to internal validity; the interaction between
infections and preterm birth may also be independent from emotional factors, thus may
have affected internal validity of the study as well.
Ethical Procedures
Approval to perform this study was obtained from the Ethics and Research
Committees at the National Institute of Perinatology in Mexico City, and Walden
University’s Institutional Review Board (IRB) approval was also required.
This study did not pose any potential physical or psychological harm for the
participants. The participation of each woman in the initial data collection lasted
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approximately 35 minutes. Pregnant women received information regarding the nature of
the study and the measurements characteristics. Participants were informed that their
decision whether or not to participate in this study in no way affected their treatment at
the Perinatology Institute, nor they would have had benefits for participating in the study.
Each woman that agreed to participate signed an informed consent letter that guaranteed
her confidentiality. The informed consent stated that all records will remain confidential
and only the researcher will have access to them. In order to maintain the confidentiality
of the participants, all participants were assigned a study number and the names of the
participants were only accessible to the main researcher. The participants’ names were
not disclosed to others. A copy of informed consent can be found in Appendix A.
The MBMD and SSRQ results were available to all participants who wished to
know their results, after pregnancy termination. Participants let the researcher know this
upon study enrollment and contacted the researcher after delivery.
Summary
This was a prospective cross-sectional study that took place at the National
Institute of Perinatology in Mexico City which included pregnant women from ages 18 to
40 years old in any of the three trimesters of pregnancy. Participants were assessed at
study enrollment and were followed until delivery. The study aimed to explore causal
effects between emotional factors, specifically stress/anxiety, depression, and emotional
lability, and pregnancy complications; and the effects of social support on emotional
factors of pregnant women. At study enrollment, women answered a demographical
questionnaire, the MBMD test and the Sarason Social Support Questionnaire. After
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delivery, a second data collection took place in which the researcher searched for
pregnancy outcome information in the participant’s medical records.
Three research questions were evaluated. The first one evaluated the relationship
between stress/anxiety, depression, and emotional lability with the development of
preeclampsia, abruptio placentae, preterm birth, or low birthweight for gestational age. A
logistic regression was performed for each dependent variable; controlling for the age of
mother, the number of previous pregnancies, and the number of infections during
pregnancy. The second research question was explored by performing a MANCOVA in
which the relationship between social support and stress, depression, and social lability
was evaluated. A factorial ANOVA was used to answer the third research question that
considered if there were differences between birthweight of the offsprings of mothers
who experienced high levels of anxiety or emotional lability, compared to those who not.
All participants signed an informed consent letter and were assigned a number
upon study enrolment so all their information remained confident and the I was the only
one who had access to it.
The following chapter includes the results of this study. It explains the data
collection process, the descriptive statistics and the results from the statistical analyses
that were performed in order to answer the three research questions of this study.
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Chapter 4: Results
Introduction
The purpose of this study was to evaluate the effects of stress/anxiety, depression,
and emotional lability on the development of pregnancy complications. For this matter,
three research questions and hypotheses were proposed. The first hypothesis indicated
that there is a significant relationship between stress/anxiety, emotional lability, and
depression and the development of preeclampsia, abruptio placentae, preterm labor, and
low birthweight for gestational age; the second hypothesis stated that the availability of
social support has a significant relationship with the presence of stress/anxiety, emotional
lability, and/or depression during pregnancy; the third hypothesis stated that there is a
difference in newborn birthweight between pregnant women who experience high levels
of stress/anxiety, depression, or high emotional lability scores during pregnancy and
those who do not.
In this chapter, the results of the study are presented. The first part of the chapter
describes the data collection process; it explains how many participants were included
and the number of participants who were eliminated from the study due to incomplete
data or the inability to evaluate their pregnancy outcomes. The second part of the chapter
describes the demographic characteristics of the participants and includes their marital
status, social income status, age at current pregnancy, gestational week at which the
evaluation took place, and body mass index at the beginning of pregnancy. The third part
of the chapter includes the descriptive statistics of the variables evaluated in this study,
such as stress/anxiety scores; depression scores; emotional lability scores; number of
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participants who developed preeclampsia, abruptio placentae, or preterm birth; and
newborn’s weight, size, and Apgar scores. The last three parts of the chapter describe the
data screening procedures that were performed before the analysis and the results of the
statistical analyses performed. For Hypothesis 1, logistic regression analyses were
performed; for Hypothesis 2, a MANCOVA was executed; for Hypothesis 3, three sets of
factorial ANOVA were computed.
Data Collection
All participants were women attended at the National Institute of Perinatology in
Mexico City. Two hundred eighty-one women were invited to participate; 11 women
refused to participate, and 270 agreed to do so. From the 270 who participated, 16 did not
complete the MBMD test appropriately and had to be eliminated. The remaining 254
participants were followed until pregnancy termination, and the information regarding
pregnancy outcomes was obtained from their medical records. Seven women did not
deliver at the National Institutes of Perinatology and had to be located by phone or email
to obtain information regarding pregnancy termination and newborn variables. Three of
the seven women who did not deliver at the National Institute of Perinatology could not
be found. From the 251 participants whose information was gathered at pregnancy
termination, nine participants had to be eliminated because of missing data for some
variables. The total number of participants who had a complete evaluation at study
enrollment and complete pregnancy outcome information was 242. The first stage of the
data collection process, which was the recruitment and evaluation of participants, lasted 2
months. The second phase of the data collection process, when several variables related
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to pregnancy outcomes and newborn conditions were obtained from the medical records,
lasted 3.5 months.
Demographics Results
The study included 242 pregnant women ranging in age from 18 to 43, with a
mean age of 29.59 and a standard deviation of 6.85. The mean evaluation week was
31.54, with a standard deviation of 5.10. The mean number of pregnancies for
participants was 2.42 (1.39). The body mass index mean prior to current pregnancy was
25.91 (5.17). The mean height for participants was 1.58 meters, with a standard deviation
of 0.06 (see Table 1).
Table 1
Maternal Descriptive Statistics
Maternal
Age
Mean
Median
SD
Minimum
Maximum

29.59
29.50
6.86
18
43

Evaluation Number of BMI Before
Height
Week
pregnancies Pregnancy
31.54
32.00
5.103
21
40

2.42
2,00
1.39
1
8

25.9126
24.9000
5.17279
17.10
51.51

1.5800
1.5800
.06996
1.30
1.81

Regarding the social status of participants, as shown in Table 2, 43.8% of
participants were married, 21.5% were single, and 34.7% were in a relationship. Of the
242 participants, 232 had a monthly family income that ranged from 1 to 10,000 Mexican
pesos, which is considered low income; and 10 participants had a monthly family income

61
that ranged between 11,000 and 84,000 Mexican pesos, considered as medium income.
No high-income participants were included in this study (see Table 2).
Table 2
Social Status and Monthly Family Income

Social status

Married
Single
In a relationship
Total
Family income 0-10,000
Mexican pesos
11,000-84,000
Mexican pesos
Total

Frequency Percent
106
43.8
52
21.5
84
34.7
242
100.0
232

95.9

10

4.1

242

100.0

Descriptive Statistics
Cesarean-section was the most common method of delivery, accounting for
76.9%. The remaining 23.1% had vaginal deliveries. Low-weight for gestational age was
present in 15.3% of delivered babies, whereas 4.5% were considered as hypertrophic. The
rest of the babies born from participants, 80.2%, had normal weight for gestational age
(see Table 3).
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Table 3
Newborn Weight for Gestational Age

Low Weight
Normal Weight
High Weight
Total

Frequency

Percent

Valid Percent

37
194
11
242

15.3
80.2
4.5
100.0

15.3
80.2
4.5
100.0

Cumulative
Percent
15.3
95.5
100.0

As the National Institute of Perinatology is considered a concentration hospital for
high-risk pregnancies, many participants had comorbidities. The most common illnesses,
as shown in Table 4, were type 2 diabetes in 5.8%, gestational diabetes in 14.9%,
hypothyroidism in 10.7%, cardiopathy in 2.5%, epilepsy in 2.9%, asthma in 2.5%, and
drug use in 2.5% of participants. Of the 242 women evaluated, fifteen women developed
preeclampsia, 37 women delivered preterm, and four women had premature abruption of
the placenta. Results are presented in Table 5.
Table 4
Maternal Illness

None
Diabetes mellitus 1
Diabetes mellitus 2
Gestational diabetes
Hyperthyroidism
Hypothyroidism
Arthritis
Lupus
(table continues)

Frequency
106
2
14
36
4
26
1
2

Percent
43.8
0.8
5.8
14.9
1.7
10.7
0.4
0.8
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Cardiopathy
Fibromyalgia
Asthma
Psychopathology
Drug consumer
Deep venous
thrombosis
Epilepsy
Placental acretism
Bulimia
Thrombocytopenia
Cancer history
Autoimmune
thrombocytopenic
purpura
Myasthenia gravis
Uterine myomatosis
Scleroderma
Coagulation disorder
Congenital adrenal
hyperplasia
Vitiligo
Bone dysplasia
Atopic dermatitis
McCune Albright
Erythema nodoso
Hepatopathy
Total

Frequency
6
1
6
4
6

Percent
2.5
0.4
2.5
1.7
2.5

1

0.4

7
3
1
1
1

2.9
1.2
0.4
0.4
0.4

2

0.8

1
2
1
1

0.4
0.8
0.4
0.4

1

0.4

1
1
1
1
1
1
242

0.4
0.4
0.4
0.4
0.4
0.4
100.0
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Table 5
Pregnancy Complications

Preeclampsia
Preterm birth
Abruptio placentae
None of the above
Total

Frequency
15
37
4
186
242

Percent
6.2
15.3
1.7
76.8
100.0
Psychosocial Factors

Total social support scores for participants had a mean of 15.88, with 54 being the
maximum score possible in the SSQ. The mean for social support satisfaction scores was
32.32, 36 being the maximum score possible. The mean of the overall total social support
score obtained through the SSQ from participants was 48.20, with 90 being the maximum
achievable score. Total social support scores were divided into four categories, as shown
in Table 6. Two percent of participants had low social support, 40.9% had medium-low
social support, 50% had medium-high social support, and 6.6% of participants had high
social support.
The mean score for stress/anxiety was 66.36, the mean depression score was
54.70, and the mean score for emotional lability was 59.71. The maximum possible score
for these three variables was 100 (see Table 7). According to the MBMD manual (Millon
et al., 2006), scores between 60 and 74 are suggestive but not sufficiently indicative of
symptom pathology; scores of 75 to 84 suggest the presence of the disorder; and scores of
85 and above strongly support the prominence of the pathological symptom (Millon et
al., 2006)
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Table 6
Categories of Total Social Support

Low social support
Medium-low social
support
Medium-high social
support
High social support
Total

Frequency
6

Percent
2.5

99

40.9

121

50.0

16
242

6.6
100.0

Table 7
Stress/Anxiety, Depression, and Emotional Lability Scores

Mean
Median
SD
Minimum
Maximum

Stress/Anxiety
Score
66,36
71,50
23,97
5
105

Depression Score
54.70
64.00
28.84
5
105

Emotional
Lability Score
59.71
62.00
16.21
10
95

Preanalysis Data Screening
Before performing multivariate analysis, I screened the data for outliers.
Normality, linearity, and homoscedasticity were evaluated. Univariate screening for
outliers of grouped data with stem and leaf plots was performed, but no outliers were
eliminated. Multivariate screening for ungrouped data was performed for 14 numerical
variables using Mahalanobis distance. Considering that the critical value for X2 at p <
0.001 with 14 degrees of freedom is 36.123, I eliminated cases with a Mahalanobis
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distance greater than 36.123 from further analysis. Eight cases were eliminated in this
process. Thus, for multivariate analyses, 234 cases were included.
To evaluate univariate normality, histograms, Q-Q plots, skewness, kurtosis, and
Kolmogorov-Smirnov tests of normality were performed for numerical variables.
Levene’s test for equality of variances showed homogeneity of variances because no
values were significant. Lastly, homogeneity of variance-covariance matrices was
evaluated within MANOVA by calculating Box’s test of equality of variance. As Box’s
test was not significant, equality of covariance was concluded.
Hypothesis 1 Results
Logistic Regression Analysis for Preeclampsia
An Enter logistic regression was conducted to evaluate which independent
variables (maternal age, social status, family income, total social support, stress/anxiety,
depression, and emotional lability) were predictors of preeclampsia. A 95% confidence
interval was used. Data screening led to the elimination of eight outliers. Logistic
regression results showed that the overall model fit of eight predictors was moderate (2log Likelihood = 105.075), but the model was not statistically reliable to distinguish
between preeclampsia and nonpreeclampsia (X2(8) = 6.360, p = 0.07). The model
correctly classified 93.6% of the cases. Wald statistic showed that being single
significantly predicts preeclampsia in this model. Regression coefficients are presented in
Table 8. The odds ratio for the significant variables indicates increased likelihood of
preeclampsia development.
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Table 8
Regression Coefficients for Preeclampsia
B
Wald
df
p
OR
Maternal age
0.019
0.198
1
0.657
1.020
Married
0.462
0.385
1
0.535
1.587
Single
1.504
3.906
1
0.048
4.498
Family income
-0.691
0.363
1
0.547
0.501
Stress/anxiety
-0.003
0.043
1
0.837
0.997
Depression
0.014
1.341
1
0.247
1.014
Emotional lability
0.001
0.001
1
0.979
1.001
Social support
0.025
1.014
1
0.314
1.025
Constant
-5.076
3.643
1
0.056
0.006
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval.
Logistic Regression Analysis for Preterm Birth
A logistic regression was conducted to evaluate which independent variables
(maternal age, social status, family income, total social support, stress/anxiety,
depression, and emotional lability) were predictors of preterm birth. Data screening led to
the elimination of eight outliers. Logistic regression results showed that the overall model
fit of eight predictors was fair (-2log Likelihood = 189.511), but the model was not
statistically reliable to distinguish between preterm birth and nonpreterm birth (X2 (8) =
14.789, p = 0.063). The model correctly classified only 84.2% of the cases. Wald statistic
showed that the variables single and social support significantly predict preterm birth in
this model. Regression coefficients are presented in Table 9. The odds ratio for the
variable single indicates increased likelihood of preterm birth development. However, the
odds ratio for social support indicates little change in the likelihood of preterm birth
development.
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Table 9
Regression Coefficients for Preterm Birth
B
Wald
df
p
OR
Maternal age
0.021 0.516
1
0.473 1.021
Married
0.316 0.596
1
0.440 1.371
Single
1.396 4.340
1
0.037 4.041
Family income
0.602 0.470
1
0.493 1.826
Stress/anxiety
-0.019 2.673
1
0.102 0.981
Depression
-0.003 0.155
1
0.694 0.997
Emotional lability
0.017 1.160
1
0.282 1.017
Social support
-0.043 5.517
1
0.019
.957
Constant
2.761 2.120
1
0.145 15.816
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval.
Logistic Regression Analysis for Abruptio Placentae
A logistic regression was conducted to evaluate which independent variables
(maternal age, social status, family income, total social support, stress/anxiety,
depression, and emotional lability) were predictors of abruptio placentae. Data screening
led to the elimination of eight outliers. Logistic regression results showed that the overall
model fit of 8 predictors was good (-2log Likelihood = 28.657) but the model was not
statistically reliable to distinguish between abruptio placentae and non-abruptio placentae
(X2 (8) = 11.826, p = 0.159). The model correctly classified 98.3% of the cases. Wald
statistic showed that the family income significantly predicts abruptio placentae in this
model. Regression coefficients are presented in Table 10. Odds ratio for the variable
family income shows increased likelihood of abruptio placentae development.
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Table 10
Regression Coefficients for Abruptio Placentae

Maternal Age
Married
Single
Family income
Stress/Anxiety
Depression
Emotional Lability
Social Support

B

Wald

df

p

-0.027
-16.580
-17.999
3.260
-0.112
0.009
0.073
0.016

0.089
0.000
0.000
4.071
2.824
0.120
1.521
0.088

1
1
1
1
1
1
1
1

0.766
0.997
0.996
0.044
0.093
0.729
0.217
0.767

OR

0.973
0.000
0.000
26.044
0.894
1.010
1.075
1.017
2367358568.
Constant
21.585 0.000 1 0.996
87
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval.
Logistic Regression Analysis for Low Weight for Gestational Age
A logistic regression was conducted to evaluate which independent variables
(maternal age, social status, family income, total social support, stress/anxiety,
depression, and emotional lability) were predictors of low-weight for gestational age.
Data screening led to the elimination of eight outliers. Logistic regression results showed
that the overall model fit of 8 predictors was poor (-2log Likelihood = 192.570) and the
model was not statistically reliable to distinguish between low-weight for gestational age
and non-low-weight for gestational age (X2(8) = 4.910, p = 0.767). The model correctly
classified 85% of the cases. Wald statistic showed that the variables entered in the model
do not significantly predict low-weight for gestational age. Regression coefficients are
presented in Table 11.

70
Table 11
Regression Coefficients for Low Weight for Gestational Age
B

Wald

df

p

OR

Maternal Age
-0.001 0.001 1 00.95
.999
Married
0.649 2.055 1 0.152 1.914
Single
0.327 0.344 1 0.558 1.387
Family Income
0.236 0.045 1 0.832 1.266
Stress/Anxiety
0.013 1.383 1 0.240 1.013
Depression
-0.006 0.698 1 0.403 0.994
Emotional Lability
-0.017 1.246 1 0.264 0.983
Social Support
0.007 0.146 1 0.702 1.007
Constant
-2.194 1.198 1 0.274 0.111
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval.

Hypothesis 2 Results
MANCOVA Results
Multivariate analysis of covariance (MANCOVA) was performed to determine
the effect of social support category on stress/anxiety, depression, and emotional lability
scores while controlling for maternal age at time of pregnancy and number of
pregnancies. Prior to the test, outliers were eliminated. MANCOVA results revealed a
significant difference among the social support categories on the combined dependent
variables, Pillai’s Trace = 0.018, F (9,684) = 3.125, p = 0.001, multivariate n2 = 0.39.
The covariates (maternal age and number of pregnancies) did not significantly influence
the combined dependent variables. Analysis of covariance (ANCOVA) was conducted on
each dependent variable as a follow-up test to MANCOVA. Results are shown in Table
12. Although Pillai’s Trace was not significant for influences of number of pregnancies
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on the combined dependent variables, the ANCOVA reported significant differences
between number of pregnancies and stress scores [F (3,228) = 5.893 , p = 0.016, partial
n2= 0.025].
Table 12
ANCOVA Summary Table for Social Support on Stress/Anxiety, Depression, and
Emotional Lability
DV
SS
df
MS
F
p
n2
Stress/Anxiety
5876.63
3
1958.88 3.762 0.012 0.047
Depression
20075.75
3
6691.92 9.050 0.000 0.106
EL
677.03
3
225.67 0.842 0.472 0.011
Maternal Age
Stress/Anxiety
1282.01
1
1282.01 2.462 0.118 0.011
Depression
451.22
1
451.22 0.610 0.436 0.003
EL
301.34
1
301.34 1.124 0.290 0.005
No. pregnancies Stress/Anxiety
3068.47
1
3068.47 5.893 0.016 0.025
Depression
1850.76
1
1850.76 2.503 0.115 0.011
EL
237.52
1
237.52 .886 0.348 0.004
Within
Stress/Anxiety
118710.63 228
520.66
Treatments
Depression
168596.57 228
739.46
EL
61113.78 228
268.04
Total
Stress/Anxiety 1152572.00 234
Depression
896691.00 234
EL
891525.00 234
Corrected Total Stress/Anxiety
130097.54 233
Depression
193782.35 233
EL
62392.35 233
Note. DV = dependent variable; df = degrees of freedom; SS = sum of squares; MS =
mean of squares; EL = emotional lability.
Source
Social Support

A comparison of adjusted means show that there is a difference of 19.51 points in
stress/anxiety scores between medium-low social support and high social support and a
difference of 31.76 points in depression scores between medium-low social support and
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high social support . Table 13 presents adjusted and unadjusted means for stress/anxiety,
depression and emotional lability by social support category.
Table 13
Adjusted and Unadjusted Means for Stress/Anxiety, Depression, and Emotional Lability
Dependent
Variable
Stress/Anxiety

Total Social
Adjusted
SD
Support
Mean
Low
68.137a
9.318
a
Medium-low
71.125
2.349
a
Medium-high
63.632
2.107
a
High
51.607
6.158
a
Depression
Low
62.645
11.105
a
Medium-low
64.835
2.799
a
Medium-high
48.830
2.511
a
High
33.075
7.338
a
Emotional Lability Low
59.289
6.686
a
Medium-low
61.282
1.685
a
Medium-high
58.678
1.512
a
High
54.728
4.418
Note. Covariates appearing in the model are evaluated at the following values:
Maternal Age = 29.53, No. Pregnancies = 2.42.
Hypothesis 3 Results
Three sets of factorial ANOVA were performed to evaluate the effects of
stress/anxiety, depression and emotional lability on newborn weight, and the possible
interaction effects among them.
Factorial ANOVA Stress/Anxiety, Emotional Lability, and Birthweight
Data were screened to ensure that assumptions of factorial ANOVA were met.
Univariate and multivariate outliers were evaluated and eight outliers were eliminated.
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Table 14
Descriptive Statistics on Interactions Between Stress and Emotional Lability
With Newborn Weight as Dependent Variable
Stress
Low

High

Total

Emotional Lability
Low
High
Total
Low
High
Total
Low
High
Total

Mean
3013.19
2982.78
2999.03
2903.50
2865.38
2870.15
2967.66
2882.90
2902.09

SD
536.504
565.585
545.564
559.677
448.847
462.477
543.634
468.197
486.381

N
31
27
58
22
154
176
53
181
234

In order to identify interaction effects between factors, line plots of the cell
means were performed. Line plots of Stress/Anxiety and Emotional Lability variables
show no interaction between factors. Lines show that higher levels of stress are related
lower newborn weight (See Figure 1 and Figure 2).
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Figure 1. Interaction of stress/anxiety and emotional lability on newborn weight.
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Figure 2. Interaction of emotional lability and stress/anxiety on newborn weight.

A 2X2 factorial analysis of variance was performed to investigate newborn
birthweight differences in stress and depression category among pregnant women.
Test’s results in Table 15 show that newborn weight is not significantly different in
women with low and high levels of stress and low and high levels of emotional lability.
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Table 15
ANOVA Summary Table for Stress/Anxiety and Depression on Newborn Weight
Source

SS

df

MS

F

p

n2

Between treatments
765990.53a
3
255330.18 1.080 00.38
0.014
Stress
425335.81
1
425335.81 1.800 0.181
0.008
Emotional Lability
38738.06
1
38738.06
0.164 00.66
0.001
Stress x EL
489.16
1
489.160
0.002 00.964 0.000
Within treatments
54354023.40 230 236321.84
Total
2025903040.00 234
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares: EL =
emotional lability
Factorial ANOVA Stress/Anxiety, Depression, and Birthweight
Data were screened to ensure that assumptions of factorial ANOVA were met.
Univariate and multivariate outliers were evaluated and eight outliers were eliminated.
Means and standard deviations were calculated for all variables before checking
interactions (see Table 16).
Table 16
Descriptive Statistics on Interactions Between Stress and
Depression With Newborn Weight as Dependent Variable
Stress
Low

High

Total

Depression
Low
High
Total
Low
High
Total
Low
High
Total

Mean
2929.41
3217.86
2999.03
2801.50
2891.66
2870.15
2866.94
2922.52
2902.09

SD
541.824
515.764
545.564
498.600
450.373
462.477
522.077
464.993
486.381

N
44
14
58
42
134
176
86
148
234
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In order to identify interaction effects between factors, line plots of the cell
means were performed. The line plots of Stress/Anxiety and Depression show interaction
between factors. Lines show that high stress scores are related to lower birthweight, but
low stress scores combined with high depression scores, are not related to low weight for
gestational age (see Figure 3).

Figure 3. Interaction of depression and stress/anxiety on newborn weight.
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Figure 4. Interaction of stress/anxiety and depression on newborn weight.

A 2X2 factorial analysis of variance was performed to investigate newborn
birthweight differences in stress and depression category among pregnant women.
ANOVA results, presented in Table 17, show a significant main effect of stress
[F(1,230) = 7.10 , p = 0.008, partial n2 = 0.030], and depression [F(1,230) = 4.94 , p =
0.027, partial n2= 0.021]. Interaction between factors was not significant [F(1,230) =
1.35 , p = 0.246, partial n2= 0.006].
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Table 17
ANOVA Summary Table for Stress/Anxiety and Depression on Newborn Weight
SS
df
MS
F
p
n2
1868299.193
3
622766.40 2.690 0.047 0.034
1644039.50
1
1644039.50 7.101 0.008 0.030
1142864.11
1
1142864.11 4.936 0.027 0.021
Stress x Depression
313458.53
1
313458.53 1.354 0.246 0.006
Within treatments
53251714.739 230 231529.195
Total
2025903040.00 234
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares; EL =
emotional lability
Source
Between treatments
Stress
Depression

Factorial ANOVA Depression, Emotional Lability, and Birthweight
Data were screened to ensure that assumptions of factorial ANOVA were met.
Univariate and multivariate outliers were evaluated and eight outliers were eliminated.
Means and standard deviations were calculated for all variables before checking
interactions (see Table 18).
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Table 18
Descriptive Statistics on Interactions Between Depression and Emotional
Lability With Newborn Weight as Dependent Variable
Depression
Low

High

Total

Emotional Lability
Low
High
Total
Low
High
Total
Low
High
Total

Mean
2865.83
2867.71
2866.94
3165.67
2888.85
2922.52
2967.66
2882.90
2902.09

SD
552.14
506.01
522.08
481.05
454.42
464.99
543.63
468.20
486.38

N
35
51
86
18
130
148
53
181
234

In order to identify interaction effects between factors, line plots of the cell means were
performed. Intersection of lines shows interaction between depression and emotional
lability. Lines show that higher levels of depression combined with high levels of
emotional lability are related to lower newborn weight (See Figure 5 and Figure 6).
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Figure 5. Interaction of emotional lability and depression on newborn weight.
.
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Figure 6. Interaction of depression and emotional lability on newborn weight.
A 2X2 factorial analysis of variance was performed to investigate newborn
birthweight differences in stress and depression category among pregnant women.
ANOVA results, presented in Table 19, show a significant main effect of depression on
newborn weight [F(1,230) = 3.96 , p = 0.048, partial n2= 0.017] but not for emotional
lability [F(1,230) = 2.90 , p = 0.090, partial n2 = 0.012]. Estimates of effect size
revealed low strength in associations. No post hoc tests were performed because the
variables depression and stress/anxiety only have 2 categories. Results show that
newborn weight is significantly different in women with low and high levels of
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depression.
Table 19
ANOVA Summary Table for Emotional Lability and Depression on Newborn
Weight
Source
SS
df
MS
F
p
n2
Between treatments
1379600.15
3 459866.72 1.968 0.120 0.025
Depression
924658.524
1 924658.52 3.957 0.048 0.017
Emotional Lability
678376.362
1 678376.36 2.903 0.090 0.012
Depression x EL
697031.198
1 697031.20 2.983 0.085 0.013
Within treatments
53740413.783 230 233653.97
Total
2025903040.00 234
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares; EL =
emotional lability
Summary
The results of this study were obtained by performing statistical analyses to a
database that was made through the evaluation of patients from the National Institute of
Perinatology in Mexico City. This study included a population constituted mostly by
low-income pregnant women. Different statistical tests were used to explore the
hypotheses and research questions of the study.
The logistic regression models for Hypothesis 1 were not statistically reliable to
distinguish between the two categories of dependent variables that were evaluated.
However, some statistically significant differences were found in some models. The
alternative Hypothesis 2 was supported by this research because the amount of social
support was found to interact with the levels of stress and depression in pregnant women.

84
The results for Hypothesis 3 show that stress and depression have significant effects on
newborn weight, and high stress scores are related to lower newborn weight.
In chapter 5, an overview of the research study and the results is presented. The
findings are discussed in this chapter, as well as the implications for social change of this
study. This manuscript concludes with the researcher’s point of view of the findings of
the effects of stress, depression and emotional lability on the development of pregnancy
complications.

85
Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This study was performed to evaluate the effects of psychosocial factors on the
development of pregnancy complications or poor pregnancy outcomes, such as
preeclampsia, preterm birth, abruptio placentae, and low weight for gestational age. In
this study, I also sought to determine if the amount of social support may influence
stress/anxiety or depression levels in pregnant women. Additionally, I aimed to determine
whether there is a relationship between stress, depression, and emotional lability and
newborn weight.
Given that the current study involved obtaining information from a cohort of
pregnant women who were followed until delivery, the participants included in this study
were women in the second or third trimester of pregnancy. Although the inclusion of
women in the first trimester of pregnancy would have been appropriate, these women
were not invited to participate because this would have prolonged the time for study
completion by 3 months.
This prospective study was done thanks to the participation of patients from the
National Institute of Perinatology, who kindly spent approximately 35 minutes of their
time answering the demographic questionnaire, the MBMD test, and the SSQ.
Previous research has focused on the effects of stress and depression on the
development of pregnancy complications, mainly preterm birth and small-for-gestationalage newborns. However, there is little information regarding the consequences of
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emotional lability in pregnancy. Moreover, there are no reported studies regarding stress,
depression, and emotional lability on pregnancy outcomes in the Mexican population.
Overview
Women in the second and third trimesters of pregnancy were evaluated and
followed until delivery. All participants were patients from the National Institute of
Perinatology. This is the biggest public perinatology hospital in Mexico City, where more
than 100 pregnant women are attended every day. Two hundred eighty one women were
invited to participate, and only 11 women refused to do so. Thus, the study initially had
270 participants. The first stage of the data collection process, which was the recruitment
and evaluation of participants, lasted 2 months. After this time, all women were followed
until delivery. Following pregnancy termination, several variables related to pregnancy
outcomes and newborn conditions were obtained from the medical records. This was the
second phase of the data collection process, which lasted 3.5 months. After eliminating
those participants who did not complete correctly the MBMD test and those who did not
deliver at the National Institute of Perinatology and were not able to be reached by me, I
had a total of 242 participants with complete information for analysis. As the required
sample to have a power of 0.80 was not achieved, the power of this study with 242
participants was 0.74, considering an alpha level of 0.05.
Demographics of the Study Population
The patients who receive healthcare at the National Institute of Perinatology come
from different parts of the country, but most of the study participants were women living
in Mexico City and the surrounding urban areas. The mean age of the women during
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evaluation was 29.59 +-6.85 years. The mean number of pregnancies for participants was
2.42+-1.39. The mean of the body mass index before pregnancy in evaluated patients was
25.91(5.17). The results of this study show that we may also have a problem of increased
weight in the childbearing population, as 49.6% of the women evaluated were overweight
or obese. Although the relationship between BMI and depression or stress scores was not
directly evaluated in this study, it would be an interesting association to search for in
future studies. It has been reported that high BMI may increase obstetrical risks (Chu et
al., 2008).
This study mainly evaluated low-income women because 95.9% of participants
were of low socioeconomic status and the remaining 4.1% of women were from medium
socioeconomic status. No women from high-income families participated in this study.
Low socioeconomic status families in Mexico earn from 0 to 10,000 Mexican pesos per
month, which is a monthly income below 850 US Dollars.
Almost half of the participants (43.8%) were married, 34.7% were in a
relationship and living with the father of the baby, and the remaining 21.5% were single
and had no relation with the father of the baby at the moment of evaluation.
Mean gestational age at delivery was 38.19 weeks. The statistical analysis for the
present study did not evaluate correlations between stress and depression scores and
gestational age at delivery, but this will be done in a future study. The mean newborn
height was 48.70 cm (1.54), and the mean weight of newborns was 2904 grams (488.67).
Babies born in Mexico City tend to be smaller than those born in lower altitude zones in
Mexico or in rural areas. Mexican weight for gestational age indexes were used to
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classify the newborn’s weight into low, normal, or high weight for gestational age (Flores
Huerta & Martínez Salgado, 2012). According to these indexes, 15.3% of newborns had
low weight for gestational age because their weight was below the 10th percentile, while
80.2% had normal weight and 4.5% had high weight for gestational age, with a weight
above the 90th percentile.
From the 242 participants in this study, 136 participants had associated
pathologies and 106 were healthy. The most common pathologies present in these women
were type 2 diabetes, gestational diabetes, hypothyroidism, asthma, epilepsy, and
cardiopathy. No correlations were evaluated in this study between these pathologies and
pregnancy outcomes, nor were they included as covariates.
Three types of social support scores were obtained with the SSQ: the social
support network score, social support satisfaction score, and overall social support score.
The social support network scores obtained by participants in the SSQ had a mean of
15.88 (9.08). Given that the maximum score for social support network in Sarason’s
questionnaire is 54, the social support network that many of these pregnant women could
count on was quite small. Regarding social support satisfaction, the mean score was
32.32 (6.59). As the maximum score possible for satisfaction in the SSQ is 36, results
show that although some participants might not have had big social support networks,
many were satisfied with the social support received. The overall social support scores
for participants had a mean of 48.20 (12.07), with 90 being the maximum achievable
score. This shows that the overall social support mean for the study group was not high,
as it was barely above 45.
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Total social support scores were divided into four categories for further analysis.
Low social support was present in 2.5% of participants and medium-low social support
was found in 40.9%, whereas medium-high social support was present in 50% of
participants and high social support was present in 6.6%. Medium social support was
present in more than 80% of participants.
Stress/anxiety scores had a mean of 66.36 (23.97), and the mean for depression
scores was 54.70 (28.84). Emotional lability scores had a mean of 59.71 (16.20).
Stress/anxiety scores were the highest among the three variables. Between these three
variables, stress was the variable with the highest mean. Women in this study had higher
stress/anxiety and depression scores than those obtained with the MBMD in patients with
severe and moderate asthma (Lavoie et al., 2010) and had higher stress/anxiety and
emotional lability scores than those found in HIV-positive men and women (Cruess,
Minor, Antoni, & Millon, 2007).
Frequency of Pregnancy Complications
The incidence of preeclampsia in this study was 6.2%, which is within the
reported frequency for preeclampsia in the general population. As preeclampsia has an
incidence that ranges from to 2-6% (Chappell et al., 2008), the population studied did not
have increased prevalence of this syndrome.
Of the 15 women who developed preeclampsia, seven delivered preterm, being
considered as early onset preeclampsia, and eight delivered after week 37, considered as
late onset preeclampsia. No statistical analyses to differentiate between early onset and
late onset preeclampsia were made for this study.
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Preterm birth was the most common pregnancy complication found in this study,
accounting for 15.3%, with 37 cases. As the reported prevalence for preterm birth in the
general population is 5-10% (Dayan et al., 2006), an increased incidence of preterm birth
was found in the population studied. This may have been due to the type of population
studied, as the National Institute of Perinatology attends women who have comorbities
during pregnancy.
The less common pregnancy complication that was evaluated in this study was
abruptio placentae. Only four women had premature abruption of the placenta,
representing 1.7% of cases.
Interpretation of Hypothesis 1 Findings
Factors increasing risk for preeclampsia. A logistic regression was performed
to evaluate factors predicting the development of preeclampsia. The overall model fit was
moderate. However, in the analysis, the Wald statistic indicated that being a single
mother significantly predicts preeclampsia with an OR = 4.49 (CI 1.01-19.98). Stress and
depression scores were not significant as predictors for preeclampsia in this model. Thus,
the first alternative hypothesis, which stated that stress, depression, or emotional lability
influence the development of preeclampsia, was not supported by this study. However,
the finding that being single can increase the risk of developing preeclampsia is relevant
because single marital status has been reported as a risk factor, mostly for preterm birth
(Shah, Zao, & Ali, 2011), but not for preeclampsia. Perhaps being single affects the
development of preeclampsia through pathways different from those of stress and
depression evaluated in this study, or by increasing allostatic load biomarkers, which
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were not measured in this study. On the other hand, low socioeconomic status has been
considered a risk factor for preeclampsia (Silva et al., 2008), but in this study, family
income was not significant for the development of preeclampsia. The fact that the
majority of participants in this study were from low-income families may have influenced
the results on this matter because there was not a high income population for comparison.
Factors increasing risk for preterm birth. A logistic regression was performed
in order to evaluate predictor variables for preeclampsia. The overall model fit was fair,
and the Wald statistic showed that two variables were significant for preterm birth in this
model: being single, OR = 4.04, 95% CI [1.08, 15.03], and social support, OR = 0.95,
95% CI [0.92, 0.99]. For social support, the OR is below 1. Thus, social support reduces
by 5% the risk for preterm birth. In contrast, stress and depression scores were not
significant as predictors for preterm birth in this model; this result is similar to those of
other studies that did not find an association between stress and depression and preterm
birth (Berle et al., 2005).
The results from this analysis regarding social status and social support are similar
to those of other studies. Maternal unmarried social status was associated in a metaanalysis with increased risk of preterm birth (Shah et al., 2011), and Ancel et al. (1999)
also found increased risk for preterm birth in unmarried cohabiting and unmarried
noncohabiting women (Ancel, Saurel-Cubizolles, Renzo, Papiernik, & Bréart, 1999).
Finding a small but protective effect of social support on the development of
preterm birth in this study is relevant because social support has been reported to improve
pregnancy outcomes (Hoffman & Hatch, 1996), and lack of social support may be
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considered an important risk factor for preterm birth (Elsenbruch et al., 2007). However,
according to the results in this study, the association between social support and lower
risk for preterm birth may not be through the stress-buffering effects of social support in
these patients, as stress and depression were not significant predictors of preterm birth in
this study. On the other hand, it may be that higher levels of social support decrease stress
scores in such a way that stress no longer acts as a predictor variable for preterm birth.
Further studies are needed in order to clarify these concepts and explain the pathways by
which the presence or the lack of social support may affect pregnancy outcomes .
Lastly, it must be noted that eight patients who developed preeclampsia also
delivered preterm. Even though patients with early onset preeclampsia are at higher risk
of delivering preterm because preeclampsia develops before week 34 of gestation, it is
relevant that single maternal status was related to both preeclampsia and preterm birth as
a predicting factor. These findings may have important implications not only for social
workers, but also for clinicians, and they may help gain a broader perspective on the
importance of being accompanied and cared for during the gestational period.
Factors increasing risk for abruptio placentae. A logistic regression was
performed to evaluate factors predicting the development of abruptio placentae. The
overall model fit was moderate, and the model was not statistically reliable to distinguish
between abruptio placentae and non-abruptio placentae. However, one significant
variable was found in the model that included seven independent variables. Family
income was significant as a predictor for abruptio placentae, OR= 26.04, 95% CI [1.09,
617.78].
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Although low family income may increase the risk of low weight for gestational
age babies and preterm birth (Parker, Schoendorf, & Kiely, 1994), it is not a common risk
factor reported for abruptio placentae. Known risk factors for abruptio placentae are
multigravidity and folic acid deficiency (Hibbard & Hibbard, 1963).
The finding that low income may act as a predictor for abruptio placentae could
have been promoted by the high prevalence of low-income families evaluated in this
study, which may also explain the high variability in the confidence interval for this
variable. Further studies that include a higher number of cases with abruptio placentae
may be needed.
Factors increasing risk for newborns with low weight for gestational age. A
logistic regression was performed to evaluate factors predicting the delivery of low
weight for gestational age newborns (SGA). The overall model fit was poor, and no
variables were found to be statistically significant as predictors of low weight for
gestational age in this model. This may have been due to low sample size or to a poor
model fit, because other studies have found increased risk for SGA and low family
income (Parker et al., 1994), for maternal unmarried status (Shah et al., 2011), and for
maternal depression (Stewart, 2007). Although no statistical differences were found in
this regression model, it is believed that fetal growth and newborn weight can be
predicted by the amount of maternal social support (Feldman et al., 2000).
Interpretation of Hypothesis 2 Findings
Impact of Social Support on Stress and Depression. A MANCOVA was
performed to evaluate the effects of different social support levels on maternal scores for
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stress/anxiety, depression and emotional lability, controlling for maternal age and number
of pregnancies. Results showed that stress/anxiety scores and depression scores are
significantly influenced by social support levels, being the effect size of depression
higher (partial n2 = 0.106) than that of stress/anxiety (partial n2 = 0.047). The small
number of participants in the low social support group (n = 6) may explain the lack of
statistical differences for this group. Results indicate that higher levels of social support
are associated with lower levels of depression and lower levels of stress/anxiety in
pregnant women.
Social support is believed to affect well-being by potentially protecting the
adverse effects of stress (Cohen & Wills, 1985). Hoffman et al (1996) emphasize the
importance of social support on improving pregnancy outcomes because it may have
direct buffering effects on stressors (Hoffman et al., 1996). In this study, social support
does appear to have buffering effects on stress levels, and, more importantly, on
depression scores. The finding that social support can have direct implications on
depression scores in pregnant women is interesting because social support has mainly
been attributed a stress-buffering effect but not a depression-buffering effect. The second
alternative hypothesis, which stated that availability of social support has a significant
relationship with the presence of stress/anxiety and/or depression during pregnancy was
supported by this study.
According to the results, not only social support scores may influences stress
scores, the number of pregnancies significantly influence stress scores during pregnancy.
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This finding may help healthcare providers comprehend how emotional factors may
affect women during first time pregnancy.
Interpretation of Hypothesis 3 Findings
Impact of Stress/Anxiety, Depression and Emotional Lability on Newborn
Weight. Three sets of factorial ANOVA were performed to evaluate the impact of
stress/anxiety, depression and emotional lability on newborn weight.
Results of the 2X2 factorial analysis of variance to evaluate the effect of stress
and emotional lability showed that newborn weight is not significantly different in
women with low and high levels of stress and low and high levels of emotional lability.
Line plots of the variables stress/anxiety and emotional lability show no interaction
either. Although the effect of these variables on newborn weight it is not statistically
significant, lines show that higher levels of stress and emotional lability are related to
lower newborn weight than low stress and low emotional lability.
Results of the 2X2 factorial analysis of variance to evaluate the effect of stress
and depression showed that newborn weight is significantly different in women with low
and high levels of stress and low and high levels of depression. Although factorial
analysis did not show a statistically significant combined effect of stress and depression
on newborn weight, line plots of the variables stress/anxiety and depression show
interaction between factors. High stress scores combined with high depression scores are
related to lower newborn weight.
These results support the concept that stress and depression can affect newborn
weight and are similar to those found in other studies, which reported that maternal stress
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and severe life events can be associated to low birthweight (Khashan et al., 2008; Rondo
et al., 2003). However, other researchers have not found an association between stress
and depression with low birth weight (Berle et al., 2005; Brooke, Anderson, Bland,
Peacock, & Stewart, 1989). The finding that stress and depression scores can affect
newborn weight has relevant implications because it is highly probable that this may due
to the participation of neuroendocrine pathways that are affecting either fetal nutrient
availability or affecting fetal endocrine mechanisms. Unfortunately, no biomarkers were
measured in this study to be able to correlate them with stress, depression scores and
newborn weight. According to the line plots, the presence of high stress scores and low
depression scores may be related to lower newborn weight than high depression, and low
stress scores. This implies that high stress scores are the ones related to lower newborn
weight.
Results of the 2X2 factorial analysis of variance to evaluate the effect of
emotional lability and depression showed that newborn weight is significantly different in
women with low and high levels of depression.
Although the combined effect of emotional lability and depression on newborn
weight was not statistically significant in factorial analysis, line plots of the variables
emotional lability and depression show interaction among variables. High levels of
depression scores combined with high levels of emotional lability are related to lower
newborn weight. Low levels of depression combined with low levels of emotional lability
do not affect newborn weight according to line plots.
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The results supported the finding that increased maternal depression can be
related to low-weight for gestational age because it can affect infant growth (Nasreen et
al., 2010; Stewart, 2007). Stress and low social support have been related to emotional
lability in pregnancy (Norbeck et al., 1983), but the effects of emotional lability on
pregnancy outcomes has not been fully studied. This study did not find an association
between emotional lability and newborn weight.
Implications for Social Change and Recommendations for Action
As being a single mother may increase the probability of developing preterm birth
and preeclampsia in low-income Mexican women, social workers from the National
Institute of Perinatology should take special care of those single women being attended at
this hospital. Even though the study was not able to indicate by what mechanisms being
single could increase the probabilities of developing preterm birth or preeclampsia, it
could be related to decreased amount of social support in these women and, perhaps,
higher levels of stress or allostatic load. The creation of social support groups at this
perinatology hospital would be relevant for these patients.
The results show that the amount of social support perceived by pregnant women
can affect stress and depression scores. Thus, by focusing in the detection of those
women with low levels of social support within the population attended at the hospital,
we may be able to identify those women with higher vulnerability for experiencing
higher levels of stress or depression during pregnancy.
While being evaluated, many women commented to me their need to learn stress
management techniques and several participants referred their eagerness to participate in
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stress management activities. The establishment of a stress management program for
pregnant women at the National Institute of Perinatology would be highly appropriate
and, along with social support groups, may have an impact on pregnancy outcomes.
The results of this study can be useful in promoting social change for those
pregnant women in vulnerable psychosocial situations because they show the importance
of psychosocial well being during pregnancy and the possible impact of some emotional
aspects on pregnancy outcomes, by affecting allostatic load. Pregnancy is a delicate time
for the mother and the fetus. It is a time where neuroendocrine changes promoted by
chronic stress or depression have shown to affect immune system regulation (Wadhwa et
al., 2001) that may lead to pregnancy complications (Coussons-Read, Okun, & Nettles,
2007) or the metabolic programming of the fetus (Beijers et al., 2010; Brunton et al.,
2010). This is why the uses of education resources promoting healthy lifestyle patterns,
the establishment of stress management programs during pregnancy, and the promotion
of social support groups, especially for those single pregnant women and those in scarce
support conditions, could promote a positive impact in our society.
Limitations and Future Recommendations
Limitations
As many participants did not complete the MBMD test correctly, many were not
able to be located by the researcher after delivery, and many others had missing data, the
required sample to have a power of 0.80 was not achieved and may represent a limitation
of this study. With a sample of 242 participants, the power of this study was 0.74,
considering an alpha level of 0.05. Due to small effect sizes of stress and depression on
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the development of pregnancy complications, studies on this matter require a large
sample size, especially for multivariate statistical analyses like logistic regression, in
which many factors are evaluated at the same time. Perhaps, the sample size of this study
was not big enough to find statistical differences in the logistic regression analyses.
Furthermore, poor model fit for logistic regression analyses may not have affected results
regarding variable interactions, which may also be a limitation of this study.
Another limitation of this study was that it included mostly women from lowincome families. Women from low socio-economical status could be exposed to different
stressors or situations that may affect their emotional well being during pregnancy,
compared to those from medium or high-income families. This may render these results
less generalizable.
Additionally, this study did not include the measurement of allostatic load
biomarkers or the evaluation of immune system components. Since it is thought that
stress and depression may influence pregnancy outcomes through changes in cortisol,
pregnancy hormones, and cytokine regulation, a relevant part of the pathophysiological
mechanisms involved were not evaluated by this study. Lastly, the interaction between
pathologies present in 136 of participants with pregnancy outcomes was not evaluated in
the current study, which may also represent a limitation of the study.
Future Recommendations
Future research projects regarding the effects of stress and depression on the
development of pregnancy complications should include the evaluation of allostatic load
biomarkers, as well as immunological parameters, in order to know more in depth which
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biological pathways are involved in increasing risk for preterm birth, low-weight for
gestational age or other poor perinatal outcomes. Also, the relationship between stress
and depression with gestational hypertension and gestational diabetes could be evaluated
in follow-up studies. Future recommendations for research would also include a bigger
sample size for logistic regression in order to have adequate statistical power.
The finding that depression may be associated with higher newborn weight is interesting
and it would be appropriate to do further research on this matter to explore if this could
be related to increased cortisol levels or to a higher incidence of gestational diabetes in
depressed women. However, this finding may also be a statistical artifact, given its
counterintuitive nature.
While collecting the data, the researcher noticed many potential research gaps that
could be explored in future studies, such as the relationship between psychosocial factors
and the development of gestational hypertension and gestational diabetes.
Conclusion
Overall, the findings lend partial support to the notion that psychosocial factors
can increase the risk for pregnancy complications. Even though the mechanisms by
which emotional factors can affect pregnancy outcomes are not fully known, several
studies indicate possible contributors to neuroendocrine changes that may affect the
delicate immunorregulatory processes involved during pregnancy. Further studies are
needed in order to identify changes in biomarkers associated with these psychosocial
variables.
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The results of this study indicate that single maternal socioeconomical status, low
levels of social support, low family income, the number of pregnancies, high stress
scores, and high depression scores are elements contributing, directly or indirectly, to the
development of pregnancy complications or poor pregnancy outcomes.
Importantly, many of these factors are potentially modifiable. This means that we
could have an impact on some psychosocial factors that may be contributing to
pregnancy morbidity by creating social support groups for women in low social support
environments, and stress management programs for those women with high levels of
stress. Unfortunately, many psychosocial factors that may contribute to poor pregnancy
outcomes are also related to low socioeconomical status, which is a difficult factor to
modify in the short term. This study’s results aim to promote awareness regarding the
psychosocial conditions of the Mexican pregnant woman that may be contributing to poor
gestational outcomes.
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Appendix A: Informed Consent
Informed Consent for the Effects of Stress/Anxiety, Depression and Emotional
Lability on the Development of Pregnancy Complications Study (English)
CONSENT FORM
You are invited to take part in a research study that will evaluate the effects of
stress/anxiety, depression and emotional lability on the development of pregnancy
complications. The researcher is inviting pregnant women who are 18 to 42 years old, in
any trimester of pregnancy, who don’t have chronic hypertension, and who will be
receiving prenatal consultations at the National Institute of Perinatology to be in the
study. This form is part of a process called “informed consent” to allow you to
understand this study before deciding whether to take part.
This study is being conducted by a researcher named Dr. Estibalitz Laresgoiti, MD, who
is a PhD student at Walden University.
Background information
The purpose of this study is to evaluate if stress, depression and/or emotional lability
during pregnancy can be associated to the development of preeclampsia, abruptio
placentae, preterm birth and low birthweight for gestational age babies. This study
will also appraise if the amount of perceived social support may influence the levels
of stress, anxiety, depression and emotional lability. This study will also assess if
women with higher levels of stress or emotional lability deliver babies with lower
birthweight.
Approximately 300 pregnant women will be included in this study. All pregnant women
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who receive prenatal healthcare at the National Institute of Perinatology, who accept to
participate by signing the Statement of Consent will be included in the study.
Procedures
If you agree to be in this study, you will be asked to: complete the administration of two
written tests. The first one will evaluate the level of stress, anxiety or depression that you
may be experiencing during pregnancy. The second test will help the researcher know the
amount of perceived social support that you have during this pregnancy. Information
regarding your age, your socioeconomical status and your social status will also be
needed. The participants will dedicate approximately 35 minutes of their time to answer
the written tests. You will then be followed until pregnancy termination when the
researcher will record if you developed pregnancy complications and your pre pregnancy
and post-delivery weight in your medical record. The researcher will not contact you at
this time because the follow up data will be retrieved from the medical record. Your
baby´s birthweight and Apgar will also be obtained as well from medical records.
This study will not evaluate any treatments. In this study, measurements of stress,
anxiety, depression, and emotional lability will be performed during pregnancy. After
delivery, the development of pregnancy complications and birth conditions of your baby
will be recorded. Afterwards, the researcher will evaluate if the levels of stress, anxiety
depression or emotional lability can be correlated with the development of pregnancy
complications.
Voluntary Nature of the Study
This study is voluntary. Everyone will respect your decision of whether or not you
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choose to be in the study. No one at the National Institute of Perinatology will treat you
differently if you decide not to be in the study. If you decide to join the study now, you
can still change your mind later. You may stop at any time.
If you agree to participate in this research study, you will be asked to sign the Statement
of Consent located below this Informed Consent Form. By accepting to participate, you
agree to answer the Millon Behavioral Medicine Diagnostic Test, which will help us
measure the parameters previously mentioned, and the Social Support Questionnaire that
will evaluate the level of perceived social support by the participant during pregnancy.
The participant will commit to stay in touch with the researchers so they can follow her
pregnancy until delivery, which may take place at the National Institute of Perinatology,
or, if not possible, at another hospital.
Risks and Benefits of Being in the Study:
Being in this type of study may involve some risk of the minor discomforts that can be
encountered in daily life, such as becoming upset due to test administration. However,
there are no known risks for the tests that will be used in this study. Being in this study
would not pose risk to your safety or wellbeing.
If you decide to participate in this study, the benefits for you and your baby will not be
directly reflected in the short term. The information that will be obtained in this study
may allow us to implement new parameters in health care attention for the pregnant
woman, and establish outlines for the prevention of pregnancy complications. In this
study, we pretend to evaluate the psychosocial factors that can be modified in order to
improve maternal and newborn outcomes.
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Payment
The participation in this study will have no monetary cost for any participant. Neither the
participant will receive any type of compensation for her participation in this study. Your
participation in the study is voluntary and you are free to withdraw at any time. Your
decision to participate in this study will not affect your relationship with the National
Institute of Perinatology neither the quality of the health care services that you receive as
a patient of this Institute.
You may ask the researchers for a report of the results from the Millon Behavioral
Medicine diagnostic test and the Social Support Questionnaire after you deliver your
baby, and this will have no cost for you.
Privacy
The records of this study will be kept confidential. The demographic, psychosocial and
health related information will be kept private and will only be revised by the researcher.
During data analysis, your information will not be identified by your name; you data will
be linked to your medical record number at the National Institute of Perinatology. Only
the researcher participating in this project will be able to link the tests results with you.
Research records and databases will be saved in password-protected files. In any sort of
report that might be published, I will not include any information that will make it
possible to identify a participant. The data will only be used for research matters and will
not be used other persons not related to this study. Data will be kept for a period of at
least 5 years, as required by the university.
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Contacts and Questions
You may ask any questions you have now. Or if you have questions later, you may
contact the researcher. If you have any doubts regarding the informed consent process or
your rights as a research study participant please contact de Human Research Studies
Committee of the National Institute of Perinatology. Walden University’s approval
number for this study is _______and it expires on ___________
This project has been approved and is supervised by the Bioethics and Research
Committee of this the National Institute of Perinatology. This Committee is formed by a
group of experts that revises meticulously the research projects and the possible risks for
the participants of the study
The researcher will give you a copy of this form to keep
Statement of Consent
I have read the above information and I feel I understand the study well enough to make a
decision about my involvement.
By signing below I confirm that I have read the informed consent form for the
participation in this study, which has been given to me. My participation in this project is
entirely voluntary and I know am free to refuse to participate or finish my participation at
any moment, without this affecting the health care services I receive now, or will receive
in the future. I consent to participate in this study because I have had the opportunity to
discuss my doubts, worries and expectatives regarding this study. I have been given
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enough information regarding my participation in this research study. I understand that I
am agreeing to the terms described above.

Printed Name of Participant

_____________________________

Date of Consent

______________________________

Participant’s Signature

______________________________

Researcher’s Signature

______________________________
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Informed Consent for the Effects of Stress/Anxiety, Depression and Emotional
Lability on the Development of Pregnancy Complications Study (Spanish)
FORMA DE CONSENTIMIENTO INFORMADO
Se le invita a formar parte de un estudio de investigación que evaluará los efectos del
estrés/ansiedad, depresión y labilidad emocional en el desarrollo de complicaciones del
embarazo. El investigador esta invitando a las mujeres embarazadas, de 18 a 42 años de
edad, en cualquier trimestre del embarazo, que no tengan hipertensión crónica previa al
embarazo y que reciban atención perinatal en el Instituto Nacional de Perinatología. Esta
forma es parte del proceso llamado “consentimiento informado” que permitirá a usted
entender este estudio antes de decidir si quiere participar.
Este estudio será dirigido por la investigadora llamada Dra. Estibalitz Laresgoiti, quien es
una estudiante de doctorado en Walden University.
Antecedentes e Información General
El objetivo de este estudio es saber si el estrés, la labilidad emocional y la depresión
durante la gestación pueden estar asociados al desarrollo de preeclampsia,
desprendimiento prematuro de placenta normo inserta, parto pretérmino y con el
estado de su bebé al nacer. El estudio también evaluará si el apoyo social percibido
por la paciente durante el embarazo puede afectar los niveles de estrés, ansiedad o
depresión de la madre. Este estudio evaluará también si los pacientes con mayores de
niveles de estrés o labilidad emocional tienen bebés con menor peso al nacimiento.
Procedimientos
Si acepta participar en este estudio, se le pedirá que realice dos pruebas escritas. La
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primera prueba nos ayudará a evaluar el nivel de estrés, ansiedad o depresión que pudiera
usted estar presentando durante su embarazo. La otra prueba será un cuestionario que nos
ayudará a conocer el apoyo social con el que usted cuenta durante su embarazo. También
se solicitará a usted información sobre la edad que tiene durante este embarazo y su
estado civil. Las participantes dedicarán aproximadamente 35 minutos de su tiempo para
responder las pruebas escritas. Será usted posteriormente monitoreada por los
investigadores hasta el fin de su embarazo para evaluar si usted presentó alguna
complicación durante el mismo y cual fue el Apgar de su bebé al nacimiento. Se
registrará también el peso de su bebé al nacimiento y el peso de usted al iniciar y
terminar su embarazo. El investigador no lo contactará al final de su embarazo porque el
resto de los datos necesarios para el estudio se obtendrán de su expediente clínico.
El estudio no propone evaluar ningún tipo de tratamiento,. Lo que se hará será medir los
niveles de estrés, ansiedad y depresión durante el embarazo y se seguirá a la mujer hasta
el final del embarazo. Después del nacimiento de su bebe se revisara en su expediente
clínico si usted desarrollo alguna complicaciones del embarazo y se registrarán las
condiciones de nacimiento de su bebé. Posteriormente se evaluará si los niveles de estrés,
ansiedad o depresión en el embarazo se pueden estar relacionados con el desarrollo de
ciertas complicaciones del embarazo.

Naturaleza Voluntaria de este Estudio
Este estudio es voluntario. Todos respetaran su decisión sobre si participar o no en el
estudio. Nadie en el Instituto Nacional de Perinatología la tratará de manera diferente si
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decide no participar en este estudio. Si decide ser arte del estudio ahora, puede cambiar
de opinión posteriormente. Puede acabar su participación en cualquier momento.
Si está de acuerdo en participar en este estudio de investigación se le pedirá que firme la
declaración de consentimiento informado localizada al final de esta carta. Al aceptar
participar en el estudio, usted acepta contestar la prueba Millon de Diagnóstico de
Comportamiento para el Campo Médico, que nos ayudará a medir los parámetros antes
mencionados, y el Cuestionario de Apoyo Social de Sarason, que busca evaluar el nivel
de apoyo social percibido por la paciente durante el embarazo. La paciente se
comprometerá a mantenerse en contacto con los investigadores para que estos puedan
seguir su embarazo hasta su final, ya sea en el INPer, o en otro hospital, en caso de que el
nacimiento no haya sido en esta Institución.
Riesgos y Beneficios de Participar en este Estudio
El participar en este estudio puede involucrar algún riesgo de incomodidades menores
encontradas en el su vida diaria, como por ejemplo, estar incomoda con la administración
de las pruebas.. Sin embargo, no hay riesgos conocidos para las pruebas que se usarán en
este estudio. El participar en este estudio no pone en riesgo su seguridad y bienestar. Las
pacientes solo tendrán que dedicar aproximadamente 25 minutos para contestar las
pruebas escritas.
Si usted decide ingresar al estudio, el beneficio para usted y su hijo(a) no será directo. La
información que se obtenga podría permitir en un futuro implementar nuevas medidas de
atención y nuevos esquemas de prevención de complicaciones del embarazo. En este
estudio se pretende evaluar los factores psicosociales que podríamos modificar para
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mejorar el pronóstico materno-neonatal.
Pagos o Remuneraciones
No hay ningún costo para usted por participar en este estudio. Tampoco los participantes
de este estudio recibirán algún tipo de compensación económica o de otro tipo por
participar en el estudio. Su participación en este estudio es totalmente voluntaria y es
usted libre de terminar su participación en cualquier momento. Su dedicación de
participar en este estudio no afectará su relación con el Instituto Nacional de
Perinatología ni la calidad de los servicio de salud que recibe como paciente en este
Instituto.
Usted podrá solicitar un reporte de los estudios de los resultados de la prueba Millon y
del Cuestionario de Apoyo Social de Sarason a los investigadores al término de su
embarazo, sin generarse ningún costo por ello.
Privacidad y Confidencialidad
La información médica obtenida durante este proyecto se mantendrá como confidencial.
La información demográfica, psicosocial y relacionada a la salud será siempre
confidencial y únicamente será revisada por el investigador de este estudio. Durante el
análisis de los datos, su información no será identificada con su nombre; sus datos estarán
ligados a su número de expediente clínico del Instituto Nacional de Perinatología y solo
el investigador principal del estudio podrá relacionar sus resultados con usted. Las bases
de datos que contienen la información de las participantes se mantendrá en archivos
protegidos con contraseña. Cualquier tipo de reporte que sea publicado sobre este estudio
no contendrá información con la cual sea posible identificar a alguna participante. Los
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datos que se obtengan de este estudio serán utilizados con fines de investigación y no
serán usados por personas ajenas a este estudio.
Contactos y Preguntas
Podrá hacer preguntas en cualquier momento acerca de este estudio. En caso de alguna
duda o si requiere de mayor información se debe comunicar con la encargada del estudio.
Si tiene cualquier duda sobre el proceso de consentimiento informado o sus derechos
como un sujeto en investigación deberá ponerse en contacto con el Comité de
Investigación para estudios en Humanos en el Instituto Nacional de Perinatología. El
número de aprobación de Walden para este estudio es ____________y expira el
_________________.
La realización de este estudio ha sido aprobada y supervisada por el Comité de
Investigación y de Bioética de este hospital, quienes son un grupo de expertos que
revisan detalladamente los protocolos de estudio y el riesgo para los sujetos de estudio.
El investigador le entregará una copia de esta forma para que usted la conserve.
Declaración de Consentimiento
He leído la hoja de consentimiento informado que se me ha entregado y entiendo el
proyecto lo suficiente como para tomar una decisión sobre mi participación.
Al firmar abajo confirmo que he leído la forma de consentimiento que se me ha otorgado
para la participación en este estudio. Mi participación en el proyecto es enteramente
voluntaria y soy libre de rehusar a tomar parte o a abandonar en cualquier momento, sin
afectar ni poner en peligro mi atención médica futura.
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Consiento en participar en este proyecto, he tenido la oportunidad de plantear mis dudas,
temores, expectativas respecto al estudio. Se me ha proporcionado información suficiente
acerca de todo lo referente al estudio, han respondido todas mis preguntas. Entiendo que
estoy de acuerdo con los términos descritos anteriormente.

Nombre de la Participante

________________________

Fecha de Consentimiento

________________________

Firma de la Participante

________________________

Firma del Investigador

________________________

Appendix B: Authorization to Use or Disclose PHI for Research
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Authorization to Use or Disclose PHI for Research Purposes (English)
The top portion of this form (above the dotted line) should be completed by the
researcher. A copy of the form should be given to the research participant for his/her
personal records.
Research Participant Name: _________________
Phone:__________________________________
Address: ________________________________

Discloser of Information: National Institute of Perinatology Health Records
Recipient of Information: Estibalitz Laresgoiti Servitje
Means of disclosing information (i.e., verbal, written, etc.): Information will be
uploaded to a database for statistical analysis. Only the researcher will be able to link the
information obtained from medical records with the participant. The participant’s identity
will be concealed.
Information to be disclosed:
Medical data
Reason for the Release: This information is being released/obtained for the purpose of
evaluating the role of stress,/anxiety, depression, and emotional lability on the
development of pregnancy complications. The data that will be obtained from medical
records will be: pregnancy outcomes (development of preeclampsia, perterm labor and
abruptio placentae), development of infections during pregnancy, newborn’s Apgar and
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birthweight.
________________________________________________________________________

Authorization Provided by Research Participant:
I understand that this authorization permits the release of information between the two
parties named above.
I understand that I have the right to refuse to sign this release form.
I understand that upon release, this information will be kept confidential; my identity will
be concealed and data will not be re-disclosed outside of the specified individuals or
agencies.
I understand a photocopy of this release will be as effective as the original.
I understand this authorization will be in effect for 12 months from the date signed unless
cancelled by me in writing. Upon receipt of the written cancellation, this release will be
void.
______________________________________________________________________
Signature

Date

______________________________________________________________________
Witness

Date
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Authorization to Use or Disclose PHI for Research Purposes (Spanish)
Autorización para Liberar/Usar Información Privada
del Expediente Clínico con Fines de Investigación
La porción superior de esta forma (por arriba de la línea punteada) deberá ser llenada por
el investigador. Una copia de esta forma deberá ser entregada a la participante.
Nombre de la participante del proyecto: _________________
Teléfono:__________________________________
Dirección: ________________________________

Persona que libera la información: Expediente Clínico del Instituto Nacional de
Perinatología
Persona que recibe la información: Estibalitz Laresgoiti Servitje
Manera de liberar la información: La información obtenida del expediente clínico y de
las pruebas SSQ y MBMD se incorporará a una base de datos para hacer análisis
estadístico. Sólo la investigadora podrá enlazar la información obtenida del expediente
clínico y las pruebas con los datos de la participante.
Información que será obtenida:

Información médica

Razón para liberación de información: Esta información será liberada/obtenida con el
fin de evaluar el efecto del estrés/ansiedad, depresión y labilidad emocional en el
desarrollo de complicaciones del embarazo. La información que será obtenida del
expediente clínico será la siguiente: desarrollo de complicaciones del embarazo
(preeclampsia, parto pretérmino, desprendimiento prematuro de placenta normo inserta),
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el desarrollo de infecciones durante el embarazo, el Apgar del recién nacido y el peso del
bebe al nacimiento.
________________________________________________________________________
Autorización Dada por la Participante del Estudio de Investigación:
Entiendo que esta autorización permite la liberación de la información entre las dos
personas anteriormente mencionadas.
Entiendo que tengo el derecho de negarme a firmar esta carta de liberación.
Entiendo que al liberarse esta información, esta será mantenida como confidencial y mi
identidad se mantendrá oculta y mis datos no serán revelados a nadie fuera de este
proyecto de investigación.
Entiendo que una copia de esta carta de liberación será igual de efectiva que la original.
Entiendo que esta autorización tendrá efecto durante los doce meses siguientes a partir de
la fecha abajo mencionada a menos de que sea cancelada por mi a través de una petición
escrita. En cuanto se reciba una cancelación escrita, esta carta de liberación se invalidará.
______________________________________________________________________
Firma

Fecha

______________________________________________________________________
Testigo

Fecha
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Appendix D: Demographic Questionnaire
Demographic Questionnaire (English)
The completion of this demographic questionnaire is relevant for
determining the influence of several of factors on the results of this study. All of
these records will remain confidential.
Age: _____
Trimester at which the evaluation is taking place:
First: ______
Second: _______
Third: ________
Gestational week at which evaluation is taking place: _________
Social status:
Married ____
Single _____
Partner_____
Divorced____
Widowed_____
Woman’s weight before pregnancy: _________
Height ________
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Demographic Questionnaire (Spanish)
El llenado de este cuestionario es muy importante para determinar la influencia de varios
factores sobre los resultados del estudio. Todos los datos serán confidenciales.
Edad _____
Trimestre en el que se esta evaluando a la paciente: (Marque con una cruz )
Primero______
Segundo________
Tercero________
Edad gestacional en la que se esta evaluando: _________
Estado civil:
Casada: ____
Soltera: _____
Unión libre:_____
Divorciada _____
Viuda:_____
Peso antes del embarazo: _________
Talla _______________
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Appendix E: Permission to Use Social Support Questionnaire
The Sarason Questionnaires are in the public domain and may be obtained from
the University of Washington, Department of Psychology web site:
http://www.psych.uw.edu/psych.php#p=161
The Sarason Social Support Questionnaire and the Social Support Questionnaire
(short form) have been developed by Irwin and Barbara Sarason and their associates.
They are in PDF format (Adobe Reader required) and include the original articles that
describe them.
Permission is granted to researchers to use these instruments. However, Dr.
Sarason would appreciate information about the findings of studies in which they are
used. Anyhow, I asked Dr. Sarason for permission to use the SSQ6. Below is his
response:
From: Irwin Sarason
Subject: Re: Permission to use the short version of the Social Support Questionnaire
Date: 31 de mayo de 2012 14:48:14 PDT
To: Estibalitz Laresgoiti
Respond to: Irwin Sarason

You have my permission. There is some useful information at
http://web.psych.washington.edu/research/sarason/
Irwin Sarason
Department of Psychology
University of Washington
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On May 11, 2012, at 8:35 PM, Estibalitz Laresgoiti wrote:

Dear Dr. Sarason,
My name is Estibalitz Laresgoiti and I am a PhD student in health psychology at
Walden University. I have a medical doctorate degree, a master's in science degree in
immunology, and a master's degree in neurosciences. My background is in pregnancy
immunology and in psychoneuroimmunology. I am interested in pursuing my dissertation
in the area of stress and the development of pregnancy complications. I have been
searching for an instrument that would explore perception of social support in pregnant
women. I was fascinated when I found the short version of your Social Support
Questionnaire in the journal of Social and Personal Relationships. This journal does have
a copy of the short version of the Social Support Questionnaire, but I am not sure if the
questionnaire is available for public use. I want to ask for your permission to use it in my
dissertation study. I would truly appreciate your assistance on this matter, and any
direction you might offer.
Please feel free to contact me
Thank you in advance for your help
Sincerely,

Estibalitz Laresgoiti Servitje
PhD Graduate Student, Health Psychology Program
Walden University
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Appendix F: Short Version of the Social Support Questionnaire

Sarason, I.G., Sarason, B.R.., Shearin, E.N., & Pierce, G.R. (1987). A brief measure of
social support: Practical and Theoretical implications. Journal of Social and Personal
Relationships, 4, 497-510.
Social Support Questionnaire 6 (SSQ6) (English)
Instructions:
The following questions ask about people in your life who provide you with help or
support. Each question has two parts. For the first part, list all the people you know,
excluding yourself, whom you can count on for help or support in the manner described.
Give the person’s initials and their relationship to you (see example). Do not list more
than one person next to each of the numbers beneath the question.
For the second part, circle how satisfied you are with the overall support you have.
If you have no support for a question, check the words “No one,” but still rate your level
of satisfaction. Do not list more than nine persons per question.
Please answer all questions as best you can. All your answers will be kept confidential.
Example:
Who do you know whom you can trust with information that could get you in
trouble?
No one

1) T.N. (brother)
2) L.M. (friend)
3) R.S. (friend)

4) T.N. (father)
5) L.M. (employer)
6)

7)
8)
9)

5) fairly

3) a little

1) very

How satisfied?
6) very

4) a little

2) fairly
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satisfied

satisfied

satisfied

dissatisfied

dissatisfied

dissatisfied

1. Whom can you really count on to be dependable when you need help?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

2. How satisfied?
6) very
satisfied
3.

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

Whom can you really count on to help you feel more relaxed when you are
under pressure or tense?

No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

4. How satisfied?
6) very
satisfied

5.

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

Who accepts you totally, including both your worst and your best points?

No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

6. How satisfied?
6) very
satisfied

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

7. Who can you really count on to care about you, regardless of what is
happening to you?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)
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8. How satisfied?
6) very
satisfied
9.

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

Whom can you really count on to help you feel better when you are feeling
generally down-in-the-dumps?

No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

10. How satisfied?
6) very
satisfied

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

11. Who can you count on to console you when you are very upset?
No one

1)
2)
3)

4)
5)
6)

7)
8)
9)

12. How satisfied?
6) very
satisfied

5) fairly
satisfied

4) a little
satisfied

3) a little
dissatisfied

2) fairly
dissatisfied

1) very
dissatisfied

To score SSQ6:
1. Add total number of people for all 6 odd-numbered items. (Max. is 54). Divide by 6
for per item score. This gives you SSQ Number Score, or SSQN.
2. Add total satisfaction scores for all 6 even-numbered items. (Maximum is 36). Divide
by 6 for per item score. This gives you SSQ Satisfaction score or SSQS.
3. You can add up the SSQN score and the SSQS score to obtain the total social support
score. The maximum score will be 90.
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Cuestionario de Apoyo Social 6 (SSQ6) (Español)
Instrucciones:
Las siguientes preguntas evalúan las personas en su vida que le dan a usted ayuda o
apoyo. Cada pregunta tiene dos partes. Para la primera parte, enliste todas las personas
que conoce, excluyéndose a usted, en las que usted puede contar para ayuda o apoyo en la
manera descrita. Escriba las iniciales de esta persona y la relación con usted (vea el
ejemplo). No enliste más de una persona junto a los números debajo de la pregunta y no
enliste más de nueve personas por pregunta. Para la segunda parte, circule que tan
satisfecha se siente con el apoyo que tiene.. Si no tiene apoyo en alguna de las preguntas,
marque la palabra “Nadie”, pero de todas formas marque su nivel de satisfacción.
Por favor, conteste todas las preguntas lo mejor que pueda. Todas sus respuestas serán
confidenciales.
Ejemplo:
¿A quien conoce usted que pueda confiar con información que podría ponerla en
problemas?
Nadie

1) T.N. (hermano)
2) L.M. (amigo)
3) R.S. (amiga)

4) T.N. (padre)
5) L.M. (jefe)
6)

7)
8)
9)

¿Qué tan satisfecha está usted con este apoyo?
6) muy
satisfecha

5) algo
satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

1. Con quién puede usted realmente contar para apoyarla cuando necesita
ayuda?
Nadie

1)
2)

4)
5)

7)
8)
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3)

6)

9)

2. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

3. Con quién puede usted realmente contar para sentirse más relajada cuando
está bajo presión o está tensa?
Nadie

1)
2)
3)

4)
5)
6)

7)
8)
9)

4. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

5. ¿Quién la acepta totalmente como es, incluyendo sus mejores y sus peores
puntos?
Nadie

1)
2)
3)

4)
5)
6)

7)
8)
9)

6. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

7. ¿En quién puede usted realmente contar para cuidar de usted, sin importar
lo que le esté pasando a usted?
Nadie

1)
2)
3)

4)
5)
6)

7)
8)
9)

8. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha
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9.

¿Con quién puede usted realmente contar para ayudarla a sentir mejor
cuando se siente deprimido y abatido?

Nadie

1)
2)
3)

4)
5)
6)

7)
8)
9)

10. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

11. ¿Con quién puede usted contar para consolarla cuando se sienta molesto o
perturbado?
Nadie

1)
2)
3)

4)
5)
6)

7)
8)
9)

12. ¿Qué tan satisfecha está usted con este apoyo?
6) muy
5) algo
satisfecha satisfecha

4) poco
satisfecha

3) poco
insatisfecha

2) algo
insatisfecha

1) muy
insatisfecha

Para calificar el SSQ6:
1. Sumar el número total de las personas por las 6 preguntas nones que valoran la
red de apoyo social. El máximo es 54. Dividir entre 6 para obtener la calificación
la red de apoyo social.
2. Sumar la calificación de las preguntas pares, que valoran el grado con el cual la
persona está satisfecha con el grado de apoyo social recibido. El máximo es 36.
Dividir entre 6 para obtener la calificación de la satisfacción de apoyo social
recibido.
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3. Sumar la calificación de la red de apoyo social, más la calificación de la
satisfacción de apoyo social para obtener la calificación total de apoyo social. La
calificación máxima es 90.
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Appendix G: Permission to Use MBMD
The Millon Behavioral Medicine Diagnostic (MBMD) Test is distributed by
Pearson Assessments. I am an authorized administrator of the MBMD test. The Spanish
Q Local / MBMD Answer Sheets will be bought through Pearson’s web site, and the tests
will be scored using Pearson Assessment’s Q local software.
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Appendix H: IRB Materials Approval
Walden’s Univeristy Institutional Review Board (IRB) approved application for the study
entitled, "Effect of Stress/Anxiety, Depression and Emotional Lability on the
Development of Pregnancy Complications."
The approval # was 12-11-12-0180653 and it will expire on December 10, 2013.
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Appendix I: Tables and Additional Information
As shown in Table I1, single pregnancies were the most common, accounting for
95.5% of pregnancies. Eleven participants were pregnant with twins and only one
participant had triplets.
Table I1
Number of Babies in Uterus

1
2
3
Total

Frequency
231
10
1
242

Percent
95.5
4.1
0.4
100.0

One baby died in uterus before pregnancy termination due to unknown causes. No
placental or maternal causes were identified. The remaining 99.5% were born alive (see
Table I2).
Table I2
Alive or Deceased Newborns

Alive
Deceased
Total

Frequency
241
1
242

Percent
99.5
0.5
100.0

Mean gestational age at delivery was 38.19 weeks. The mean newborn height was
48.7 cm and the mean weight of newborns was 2904 grams (see Table I3).
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Table I3
Newborn Weight at Delivery
Gestational Age Newborn
at Delivery
weight

242
242
Missing
0
0
Mean
38.19
2904.44
Median
38.30
2904.50
Mode
38.3
2790a
SD
1.58
488.67
Minimum
31.5
1564
Maximum
41.6
4236
a. Multiple modes exist. The smallest value is shown
N

Valid

Of the 242 participants, 254 babies were born. 56.2% of babies were female and
43.8% were male. One baby had dysmorphic external genitalia and was categorized as
female after genetic evaluation.
Table I4
Newborn’s Sex

Female
Male
Total

Frequency
143
111
254

Percent
56.2
43.8
100.0

Most babies (93.8%) were born healthy. However, ten had minor malformations,
one was born with Down Syndrome, one had gastroschisis, one had cystic hygroma, one
baby was microcephalic and one had cleft palate and lip, as shown in Table I5.
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Table I5
Newborn Illness

None
Minor malformations
Trisomy 21
Gastroschisis
Cystic Hygroma
Microcephaly
Cleft lip and palate
Total

Frequency
227
10
1
1
1
1
1
242

Percent
93.8
4.1
0.4
0.4
0.4
0.4
0.4
100.0

Mean gestational age at delivery was 38.19 weeks. The mean newborn height was
48.7 cm and the mean weight of newborns was 2904 grams. The mean Apgar score at
minute 1 was 7.93 and the mean Apgar score ar 5 minutes was 8.92. Mean Silverman
Anderson scoring for babies was 1.6 (see Table I6).
Table I6
Newborn Conditions at Delivery
Gestational Age
at Delivery

Newborn
height

Newborn
weight

Apgar 1
min

242
242
242
242
Missing
0
0
0
0
Mean
38.19
48.70
2904.44
7.93
Median
38.30
49.00
2904.50
8.00
a
Mode
38.3
50.0
2790
8
SD
1.58
2.64
488.67
0.92
Minimum
31.5
36.0
1564
0
Maximum
41.6
54.0
4236
9
a. Multiple modes exist. The smallest value is shown
N

Valid

Apgar 5
min

Silverman
Anderson

242
0
8.92
9.00
9
0.67
0
10

242
0
1.60
2.00
2
.64
0
5
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The mean number of maternal infections during pregnancy was 0.91. Statistics are
shown in Table I7. Urinary tract infections, respiratory airway infections, gastrointestinal
infections and cervicovaginitis were considered.
Table I7
Number of Maternal Infections During Pregnancy

N

Valid
Missing

Mean
Median
Mode
SD
Minimum
Maximum

Number of Maternal Infections
242
0
0.91
1.00
1
0.74
1
3

Table I8
Social Support Scores

Mean
Median
SD
Minimum
Maximum

Social Support
Network
15,88
14,00
9,08
0
54

Social Support
Satisfaction
32.32
35.00
6.595
6
56

Social Support
Total Score
48.20
48.00
12.07
13
89
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